The DOI matches its Crossref record; 320 of the 339 references it cites were found in a registry or an index; 2 of the 253 sources its claims cite were checked for support.
Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements
Open accessAbstract
Melatonin has become a popular dietary supplement, most known as a chronobiotic, and for establishing healthy sleep. Research over the last decade into cancer, Alzheimer’s disease, multiple sclerosis, fertility, PCOS, and many other conditions, combined with the COVID-19 pandemic, has led to greater awareness of melatonin because of its ability to act as a potent antioxidant, immune-active agent, and mitochondrial regulator. There are distinct similarities between melatonin and vitamin D in the depth and breadth of their impact on health. Both act as hormones, affect multiple systems through their immune-modulating, anti-inflammatory functions, are found in the skin, and are responsive to sunlight and darkness. In fact, there may be similarities between the widespread concern about vitamin D deficiency as a “sunlight deficiency” and reduced melatonin secretion as a result of “darkness deficiency” from overexposure to artificial blue light. The trend toward greater use of melatonin supplements has resulted in concern about its safety, especially higher doses, long-term use, and application in certain populations (e.g., children). This review aims to evaluate the recent data on melatonin’s mechanisms, its clinical uses beyond sleep, safety concerns, and a thorough summary of therapeutic considerations concerning dietary supplementation, including the different formats available (animal, synthetic, and phytomelatonin), dosing, timing, contraindications, and nutrient combinations.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
This narrative review argues melatonin resembles vitamin D as a pleiotropic, light/dark-responsive hormone and reviews its mechanisms, clinical uses beyond sleep, safety, and supplement considerations. It emphasizes that melatonin is not simply a sleep aid, that dosing should generally be low and personalized, and that phytomelatonin may outperform synthetic melatonin in some in vitro assays.
Key findings
- The pineal gland produces about 0.1–0.9 mg melatonin daily, while gut enterochromaffin cells contain roughly 400 times more melatonin than the pineal gland, with gut levels 10–100 times greater than serum levels; production declines with age.
- In vitro, phytomelatonin showed 646% stronger COX-2 inhibition, 267–470% more potent free-radical scavenging, and 100% greater efficacy in reducing cellular ROS in a human skin cell line compared with synthetic melatonin.
- Clinical studies cited include 3 mg melatonin reducing migraine frequency comparably to amitriptyline; 10 mg nightly reducing endometriosis pain by about 40% and pain-medication use by 80%; six months of melatonin in PCOS decreasing androgens, free testosterone, hydroxyprogesterone, anti-Mullerian hormone, and LDL, with menstrual irregularities decreasing in 95%; and controlled-release melatonin reducing asleep systolic blood pressure by 3.57 mm Hg.
- Supplement quality and safety concerns include 31 over-the-counter melatonin products ranging from −83% to +478% of label claim, limited safety studies for high-dose melatonin (≥10 mg/day), and evidence that 0.3 mg restored sleep efficiency without the hypothermia and daytime melatonin elevation seen with 3 mg.
Methods
- Narrative review; no systematic search strategy or review protocol is reported.
- It synthesizes mechanistic, preclinical, and clinical literature on melatonin mechanisms, clinical uses, safety, dietary sources, supplement formats, dosing, timing, contraindications, and nutrient combinations.
- Evidence discussed includes in vitro cellular assays, animal studies, randomized controlled trials, meta-analyses, systematic reviews, cohort studies, and clinical guidelines; no new primary data are presented.
Limitations
- Stated: there are limited studies to conclude safety of high-dose melatonin (≥10 mg/day); there is a lack of significant data on nutrient combinations; bioavailability of different formats and sources remains unanswered; and in the bone-health combination trial, melatonin cannot be inferred to be responsible for the effects.
- Stated/evident: several clinical areas rely on small, older, or mixed studies—for example, endometriosis results are mixed, shift-work findings are inconsistent or show essentially no benefit, and most jet-lag dosing research is 10–20 years old or older.
- Evident: as a narrative review without systematic search or risk-of-bias assessment, selection and interpretation may be subject to bias; laboratory assessment of melatonin is also confounded by light exposure, timing, diet, season, physical activity, age, sex, genetics, and posture.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Age-related decrease in melatonin in humans. Modified from [10].](/paper-figures/19eadd4523a04943a7e254724df3dd2a/is-melatonin-the-next-vitamin-d-a-review-of-emerging-science-clinical-uses-figure-1.jpg)

![Figure 3 Inhibition of inflammation by phytomelatonin (blue bar) and synthetic melatonin (gray bar). Data are expressed as a percentage of human recombinant COX-2 inhibition. Amounts used for each were 0.030 mL (5 mg/mL). Values are derived from the original data presented in [34].](/paper-figures/ae4d6c5dc2af48a0b9fbef8c91e0e2d5/is-melatonin-the-next-vitamin-d-a-review-of-emerging-science-clinical-uses-figure-3.jpg)
![Figure 4 Free Radical Scavenging Percentage (DPPH%) by phytomelatonin (blue bar) and three synthetic melatonins (gray bars). Data are expressed as mcg/mL. Values are derived from the original data presented in [34].](/paper-figures/b70534526e78458b9b8d5677ca83e5c1/is-melatonin-the-next-vitamin-d-a-review-of-emerging-science-clinical-uses-figure-4.jpg)
![Figure 5 ROS fluorescence in human skin cell line by phytomelatonin (blue bars) and synthetic melatonin (gray bars). Data are expressed as ROS fluorescence using 50 mcg/mL for both phytomelatonin and synthetic melatonin. Values are derived from the original data presented in [34].](/paper-figures/59d02b67ff54463db436e940d586be14/is-melatonin-the-next-vitamin-d-a-review-of-emerging-science-clinical-uses-figure-5.jpg)
![Figure 6 Chemical Structure of Melatonin (CAS: 73-31-4; Wikipedia, public domain) [254].](/paper-figures/c9c06be962ee46a98f500341f22ebeed/is-melatonin-the-next-vitamin-d-a-review-of-emerging-science-clinical-uses-figure-6.jpg)
![Figure 7 Nutritional characteristics of phytomelatonin. The phytomelatonin detailed below refers to the proprietary format utilized in [34]. Graphic created using Canva.com using images from pavelnaumov (chlorella, alfalfa), Victoria Sergeeva (rice), and Walrus_d’s (melatonin). https://Canva.com accessed 27 July 2022.](/paper-figures/9aaf5d246d5543e19473b234ba4d89f1/is-melatonin-the-next-vitamin-d-a-review-of-emerging-science-clinical-uses-figure-7.jpg)
![Figure 8 Oxygen radical absorbance capacity (ORAC) of two samples of phytomelatonin (blue bars) and three types of synthetic melatonin (gray bars) [271,272].](/paper-figures/b465e38946cf4f47b4560b4b4f93e975/is-melatonin-the-next-vitamin-d-a-review-of-emerging-science-clinical-uses-figure-8.jpg)
![Figure 9 Melatonin production throughout the day. Modified from [10].](/paper-figures/581d370e5fd04cebb87e879f37c3f876/is-melatonin-the-next-vitamin-d-a-review-of-emerging-science-clinical-uses-figure-9.jpg)

Verification
Claims the paper makes
187 Not checked yet · 35 Own interpretation · 24 No basis given · 1 Partly supported · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Those with certain genotypes, such as polymorphisms in the melatonin receptor 1B (MTNR1B) gene, may require monitoring of hemoglobin A1C if they take supplemental melatonin [275,276].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Supportedcites [275] Benedict, 2022, Melatonin’s Potential Side Effects: It May Be in Your Genes, Mayo Clin. Proc. source
In “Melatonin’s Potential Side Effects: It May Be in Your Genes,” the author recommends periodic glycated hemoglobin (HbA1c) monitoring for melatonin-supplement users and says physicians should pay particular attention to carriers of the MTNR1B risk G allele. This supports the citing sentence’s qualified recommendation for people with that genotype. (LLM, conf=0.94)
- Partly supportedcites [276] Bonnefond, 2009, A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk, Nat. Genet. sourceExperimental — accuracy not yet measured
The LETTERS section reports that a variant near MTNR1B is associated with higher fasting plasma glucose and type 2 diabetes risk, and suggests a possible link through melatonin signaling. It does not study supplemental melatonin or recommend hemoglobin A1C monitoring for people with the variant; searches for supplementation and HbA1c found no such passage. (LLM, conf=0.85)
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
In the paper
“Phytomelatonin was found to have 646% stronger COX-2 inhibition (see Figure 3), 267–470% more potent free-radical scavenging ability (see Figure 4), and 100% greater efficacy in reducing cellular ROS in a human skin cell line (see Figure 5) when compared to synthetic melatonin”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.1. Mechanisms Related to Aging and Disease: Antioxidant Defense, Oxidative Stress Reduction, and Anti-Inflammatory Properties
What the sources say
- Not checked yetcites [34] Kukula-Koch, W., Szwajgier, D., Gaweł-Bęben, K., Strzępek-Gomółka, M., Głowniak, K., and Meissner, H.O. (2021). Is Phytomelatonin Complex Better Than Synthetic Melatonin? The Assessment of the Antiradical and Anti-Inflammatory Properties. Molecules, 26. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Phytomelatonin was found to have 646% stronger COX-2 inhibition (see Figure 3), 267–470% more potent free-radical scavenging ability (see Figure 4), and 100% greater efficacy in reducing cellular ROS in a human skin cell line (see Figure 5) when compared to synthetic melatonin”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.1. Mechanisms Related to Aging and Disease: Antioxidant Defense, Oxidative Stress Reduction, and Anti-Inflammatory Properties
What the sources say
- Not checked yetcites [34] Kukula-Koch, W., Szwajgier, D., Gaweł-Bęben, K., Strzępek-Gomółka, M., Głowniak, K., and Meissner, H.O. (2021). Is Phytomelatonin Complex Better Than Synthetic Melatonin? The Assessment of the Antiradical and Anti-Inflammatory Properties. Molecules, 26. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Phytomelatonin was found to have 646% stronger COX-2 inhibition (see Figure 3), 267–470% more potent free-radical scavenging ability (see Figure 4), and 100% greater efficacy in reducing cellular ROS in a human skin cell line (see Figure 5) when compared to synthetic melatonin”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.1. Mechanisms Related to Aging and Disease: Antioxidant Defense, Oxidative Stress Reduction, and Anti-Inflammatory Properties
What the sources say
- Not checked yetcites [34] Kukula-Koch, W., Szwajgier, D., Gaweł-Bęben, K., Strzępek-Gomółka, M., Głowniak, K., and Meissner, H.O. (2021). Is Phytomelatonin Complex Better Than Synthetic Melatonin? The Assessment of the Antiradical and Anti-Inflammatory Properties. Molecules, 26. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“In one of the studies, Akkermansia muciniphila and Lactobacilli species were increased in the melatonin-treated animals [46].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.3. Gut-Synthesized Melatonin the Gut Microbiome
What the sources say
- Not checked yetcites [46] Park, 2020, Melatonin in the colon modulates intestinal microbiota in response to stress and sleep deprivation, Intest Res. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Both doses of melatonin taken in the morning, approximately 6 h after the sleep midpoint, will cause a phase delay.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“For instance, 0.5 mg and 3.0 mg of melatonin taken eleven hours before the sleep midpoint will cause a phase advance, so the individual feels sleepy earlier and awakens earlier.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Trials that used higher doses of melatonin and conducted over a longer duration demonstrated even greater effects on these two sleep issues, and overall sleep quality was also significantly improved in melatonin users [1,91].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [1] Wunsch, N.-G. (2022, July 31). Sales of Melatonin 2020. Available online: https://www.statista.com/statistics/1267421/sales-of-melatonin-in-the-united-states/.
- Not checked yetcites [91] Qawasmi, 2018, Meta-Analysis: Melatonin for the Treatment of Primary Sleep Disorders, Focus source
boosteddirectn = 1,683- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Both doses improved sleep efficiency, but the higher dose impacted the biological day and night sleep patterns, the duration of non-REM sleep, and awakening time [93].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [93] Duffy, 2022, High dose melatonin increases sleep duration during nighttime and daytime sleep episodes in older adults, J. Pineal Res. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“A meta-analysis of melatonin for the treatment of primary sleep disorders analyzed nineteen studies involving 1683 individuals.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [1] Wunsch, N.-G. (2022, July 31). Sales of Melatonin 2020. Available online: https://www.statista.com/statistics/1267421/sales-of-melatonin-in-the-united-states/.
- Not checked yetcites [91] Qawasmi, 2018, Meta-Analysis: Melatonin for the Treatment of Primary Sleep Disorders, Focus source
plainn = 1,683- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- It may state two separate claims as one. 90
- Probably not a substantial claim. 46
- The quote only partly states this claim. 1
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Of note, when melatonin is taken 4 h before the sleep midpoint, i.e., at bedtime, the low dose of 0.5 mg does not shift the circadian rhythm, while the 3.0 mg dose will cause a phase delay.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Both doses improved sleep efficiency, but the higher dose impacted the biological day and night sleep patterns, the duration of non-REM sleep, and awakening time [93].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [93] Duffy, 2022, High dose melatonin increases sleep duration during nighttime and daytime sleep episodes in older adults, J. Pineal Res. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“A randomized study of people with delayed sleep-wake phase disorder found that a low dose of melatonin (0.5 mg) an hour before the desired bedtime, along with behavioral strategies for four weeks, resulted in earlier sleep onset, improved sleep efficiency during the first third of the night, and reduced subjective complaints [72].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [72] Sletten, T.L., Magee, M., Murray, J.M., Gordon, C.J., Lovato, N., Kennaway, D.J., Gwini, S.M., Bartlett, D.J., Lockley, S.W., and Lack, L.C. (2018). Efficacy of melatonin with behavioural sleep-wake scheduling for delayed sleep-wake phase disorder: A double-blind, randomised clinical trial. PLoS Med., 15. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“A 2017 systematic review [92] identified 5030 studies on melatonin and sleep, but only twelve were included to meet their criteria for randomized, controlled, and single or double-blind studies.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [92] Auld, 2017, Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders, Sleep Med. Rev. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Melatonin had a statistically significant effect on reducing sleep latency and increasing total sleep time.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [1] Wunsch, N.-G. (2022, July 31). Sales of Melatonin 2020. Available online: https://www.statista.com/statistics/1267421/sales-of-melatonin-in-the-united-states/.
- Not checked yetcites [91] Qawasmi, 2018, Meta-Analysis: Melatonin for the Treatment of Primary Sleep Disorders, Focus source
plaindirectn = 1,683- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In a Cochrane review, nine out of ten trials found that melatonin effectively reduced jet lag symptoms in travelers, especially if traveling eastward or over five time zones [74].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [74] Herxheimer, 2002, Melatonin for the prevention and treatment of jet lag, Cochrane Database Syst. Rev.
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In a small pilot study of elderly patients with a mild cognitive deficit, the ability to remember previously learned items improved, and depression decreased with melatonin [105].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [105] Zizi, 1998, Melatonin effects on sleep, mood, and cognition in elderly with mild cognitive impairment, J. Pineal Res. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Levels from infancy to adolescence increase and plateau in association with Tanner stages of puberty and then slowly decline with age starting in the late twenties [9,10].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 1. Introduction
What the sources say
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“From a basic mechanistic perspective, both have widespread effects on multiple systems and are found extensively throughout the body.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 1. Introduction
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: unclear — It is unclear why the paper says it holds.
It may state two separate claims as one.
In the paper
“Breastfed babies have the benefit of melatonin from their mother’s milk [8].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 1. Introduction
What the sources say
- Not checked yetcites [8] Caba, 2022, Breast Milk and the Importance of Chrononutrition, Front. Nutr. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Both act as hormones, affect multiple systems through their immune-modulating, anti-inflammatory functions, are found in the skin, and are responsive to sunlight and darkness.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > Abstract
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper may give no reason why it holds. It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Like vitamin D, melatonin could plausibly be treated as a required dietary nutrient, with certain individuals necessitating less, more, or fine-tuning to personalized needs for lifestyle requirements (e.g., exposure to artificial blue light at night, jet lag, shift work) or alterations in physiology, such as gene variants in melatonin receptors or metabolic response [2,3].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 1. Introduction
What the sources say
- Not checked yetcites [2] Celestin, 2021, Impact of Changes in Free Concentrations and Drug-Protein Binding on Drug Dosing Regimens in Special Populations and Disease States, J. Pharm. Sci. source
- Not checked yetcites [3] Garaulet, 2015, Common type 2 diabetes risk variant in MTNR1B worsens the deleterious effect of melatonin on glucose tolerance in humans, Metabolism source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“On average, the pineal gland produces between 0.1 and 0.9 mg of melatonin per day [4,6].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 1. Introduction
What the sources say
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Melatonin production and circadian rhythms do not develop in babies until around three months [7].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 1. Introduction
What the sources say
- Not checked yetcites [7] Rivkees, 1997, Developing circadian rhythmicity. Basic and clinical aspects, Pediatr. Clin. N. Am. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In fact, there may be similarities between the widespread concern about vitamin D deficiency as a “sunlight deficiency” and reduced melatonin secretion as a result of “darkness deficiency” from overexposure to artificial blue light.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > Abstract
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
In the paper
“Ultraviolet (UV)-B radiation is required to convert 7-dehydrocholesterol in the skin to vitamin D3 [21].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 1. Introduction
What the sources say
- Not checked yetcites [21] Wacker, 2013, Sunlight and Vitamin D: A global perspective for health, Dermato-Endocrinology source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Specifically, vitamin D and melatonin may work synergistically in the skin.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 1. Introduction
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“Its synthesis is reduced by exposure to light, with artificial light reducing a person’s melatonin production and increasing disease risk [4,6].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 1. Introduction
What the sources say
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“It has been proposed that both vitamin D and melatonin orchestrate many of their functions, especially related to redox status, at the level of the mitochondria [27].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 1. Introduction
What the sources say
- Not checked yetcites [27] Ferder, 2020, Daily and seasonal mitochondrial protection: Unraveling common possible mechanisms involving vitamin D and melatonin, J. Steroid Biochem. Mol. Biol. source
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“Numerous studies have identified melatonin as a powerful free-radical scavenger with potential protective properties against neurodegenerative disorders, epilepsy, and certain cancers.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.1. Mechanisms Related to Aging and Disease: Antioxidant Defense, Oxidative Stress Reduction, and Anti-Inflammatory Properties
boostedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Concurrent with the age-related depletions in levels of vitamin D and melatonin, there is mitochondrial dysfunction, which has implications in a variety of clinical conditions that present differently through the seasons with changing light exposure [27].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 1. Introduction
What the sources say
- Not checked yetcites [27] Ferder, 2020, Daily and seasonal mitochondrial protection: Unraveling common possible mechanisms involving vitamin D and melatonin, J. Steroid Biochem. Mol. Biol. source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Newer, in vitro data on phytomelatonin would suggest superior antioxidant, anti-radical, and anti-inflammatory effects over synthetic melatonin.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 1. Introduction
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Finally, melatonin is involved with multiple activities that include mitochondrial homeostasis, genomic regulation, modulation of inflammatory and immune cytokines, directly impacting both systemic and acute anti-inflammatory properties as well as indications around its potential role in phase separation [25,26].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 1. Introduction
What the sources say
- Not checked yetcites [25] Tan, 2015, Melatonin as a Potent and Inducible Endogenous Antioxidant: Synthesis and Metabolism, Molecules source
- Not checked yetcites [26] Loh, D., and Reiter, R.J. (2021). Melatonin: Regulation of Biomolecular Condensates in Neurodegenerative Disorders. Antioxidants, 10. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Melatonin’s dual actions can inhibit pro-oxidative enzymes (e.g., xanthine oxidase) while also acting to potentiate the critical antioxidant enzymes such as superoxide dismutase (SOD), glutathione peroxidase, and catalase, aiding in the body’s first line of immune defense and metabolic detoxification [31,32].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.1. Mechanisms Related to Aging and Disease: Antioxidant Defense, Oxidative Stress Reduction, and Anti-Inflammatory Properties
What the sources say
- Not checked yetcites [31] Ighodaro, 2018, First line defence antioxidants-superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): Their fundamental role in the entire antioxidant defence grid, Alex. J. Med.
- Not checked yetcites [32] Chitimus, D.M., Popescu, M.R., Voiculescu, S.E., Panaitescu, A.M., Pavel, B., Zagrean, L., and Zagrean, A.M. (2020). Melatonin’s Impact on Antioxidative and Anti-Inflammatory Reprogramming in Homeostasis and Disease. Biomolecules, 10. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Of interest, research has indicated that the sheer amplitude of plasma melatonin may not have as much to do with chronological age but more with the degree of pineal calcification and associated melatonin secretion [16].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 1. Introduction
What the sources say
- Not checked yetcites [16] Tan, D.X., Xu, B., Zhou, X., and Reiter, R.J. (2018). Pineal Calcification, Melatonin Production, Aging, Associated Health Consequences and Rejuvenation of the Pineal Gland. Molecules, 23. source
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Melatonin assists in mitochondrial redox balance through its ability to reduce the superoxide anion molecule from the electron transport chain and to directly scavenge free radicals [36].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.2. The Central Role of the Mitochondria
What the sources say
- Not checked yetcites [36] Reiter, R.J., Tan, D.X., Rosales-Corral, S., Galano, A., Zhou, X.J., and Xu, B. (2018). Mitochondria: Central Organelles for Melatonin’s Antioxidant and Anti-Aging Actions. Molecules, 23. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The established serotonergic and melatonergic systems may be vulnerable before establishing a stable global biota in infancy.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.3. Gut-Synthesized Melatonin the Gut Microbiome
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
In the paper
“It can stimulate the regeneration of epithelial cells [43] and has also been shown to have protective antioxidant effects on the lining of the GI tract [43].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.3. Gut-Synthesized Melatonin the Gut Microbiome
What the sources say
- Not checked yetcites [43] Kanova, M., and Kohout, P. (2021). Tryptophan: A Unique Role in the Critically Ill. Int. J. Mol. Sci., 22. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“It is suspected that the gut-brain axis is a network of complex interactions between the nervous and GI systems with major contributions from intestinal microbiota.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.3. Gut-Synthesized Melatonin the Gut Microbiome
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Unlike pinealocytes, enterochromaffin cells are not regulated by light and dark but appear affected by food intake and digestion [39,40].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.3. Gut-Synthesized Melatonin the Gut Microbiome
What the sources say
- Not checked yetcites [39] Rezzani, R., Franco, C., Franceschetti, L., Gianò, M., and Favero, G. (2022). A Focus on Enterochromaffin Cells among the Enteroendocrine Cells: Localization, Morphology, and Role. Int. J. Mol. Sci., 23. source
- Not checked yetcites [40] Yasmin, 2021, Gut melatonin: A potent candidate in the diversified journey of melatonin research, Gen. Comp. Endocrinol. source
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Low levels of melatonin may trigger an upregulation in the kynurenine pathway, and kynurenine production, as well as trigger the aryl hydrocarbon receptor (AhR) located on the outer membrane of the mitochondria [32,55,56,57,58].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.4. Kynurenine Pathway, Energy Regulation Stress Response
What the sources say
- Not checked yetcites [32] Chitimus, D.M., Popescu, M.R., Voiculescu, S.E., Panaitescu, A.M., Pavel, B., Zagrean, L., and Zagrean, A.M. (2020). Melatonin’s Impact on Antioxidative and Anti-Inflammatory Reprogramming in Homeostasis and Disease. Biomolecules, 10. source
- Not checked yetcites [55] Ferlazzo, N., Andolina, G., Cannata, A., Costanzo, M.G., Rizzo, V., Currò, M., Ientile, R., and Caccamo, D. (2020). Is Melatonin the Cornucopia of the 21st Century?. Antioxidants, 9. source
- Not checked yetcites [56] Maffei, M.E. (2020). 5-Hydroxytryptophan (5-HTP): Natural Occurrence, Analysis, Biosynthesis, Biotechnology, Physiology and Toxicology. Int. J. Mol. Sci., 22. source
- Not checked yetcites [57] Reiter, 2010, Neurotoxins: Free radical mechanisms and melatonin protection, Curr. Neuropharmacol. source
- Not checked yetcites [58] Brinkmann, 2019, The Aryl Hydrocarbon Receptor (AhR) in the Aging Process: Another Puzzling Role for This Highly Conserved Transcription Factor, Front. Physiol. source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Levels of melatonin are known to be higher in mitochondria compared with blood levels, most likely due to the greater antioxidant requirements with the copious amounts of free radicals generated through the electron transport chain [25].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.2. The Central Role of the Mitochondria
What the sources say
- Not checked yetcites [25] Tan, 2015, Melatonin as a Potent and Inducible Endogenous Antioxidant: Synthesis and Metabolism, Molecules source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Elderly individuals may also be more susceptible to serotonergic and melatonergic system errors due to known lower amounts of biota diversity.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.3. Gut-Synthesized Melatonin the Gut Microbiome
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“The release of melatonin in the gut acts in a paracrine manner to increase activity and circulation in the gastric mucosa and enhances GI motility [5,41].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.3. Gut-Synthesized Melatonin the Gut Microbiome
What the sources say
- Not checked yetcites [5] Chen, 2011, Distribution, function and physiological role of melatonin in the lower gut, World J. Gastroenterol. source
- Not checked yetcites [41] Fowler, 2022, Circadian Rhythms and Melatonin Metabolism in Patients With Disorders of Gut-Brain Interactions, Front. Neurosci. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Ultimately, the gut microbiota may influence CNS function and, over time, could cause neurological diseases, including Alzheimer’s disease, mood and anxiety disorders, multiple sclerosis (MS), Parkinson’s disease, and migraines.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.3. Gut-Synthesized Melatonin the Gut Microbiome
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“It may be that declining melatonin levels with age and, thus, less protection of the mitochondria from oxidative stress may be contributors to preclinical changes and, ultimately clinical symptoms.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.2. The Central Role of the Mitochondria
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Melatonin is derived from serotonin using 5-hydroxytryptophan (5-HTP) and tryptophan [32,55].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.4. Kynurenine Pathway, Energy Regulation Stress Response
What the sources say
- Not checked yetcites [32] Chitimus, D.M., Popescu, M.R., Voiculescu, S.E., Panaitescu, A.M., Pavel, B., Zagrean, L., and Zagrean, A.M. (2020). Melatonin’s Impact on Antioxidative and Anti-Inflammatory Reprogramming in Homeostasis and Disease. Biomolecules, 10. source
- Not checked yetcites [55] Ferlazzo, N., Andolina, G., Cannata, A., Costanzo, M.G., Rizzo, V., Currò, M., Ientile, R., and Caccamo, D. (2020). Is Melatonin the Cornucopia of the 21st Century?. Antioxidants, 9. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“Quinolinic acid is a neurotoxin, while kynurenic acid has neuroprotective properties [32,55,56,57,58].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.4. Kynurenine Pathway, Energy Regulation Stress Response
What the sources say
- Not checked yetcites [32] Chitimus, D.M., Popescu, M.R., Voiculescu, S.E., Panaitescu, A.M., Pavel, B., Zagrean, L., and Zagrean, A.M. (2020). Melatonin’s Impact on Antioxidative and Anti-Inflammatory Reprogramming in Homeostasis and Disease. Biomolecules, 10. source
- Not checked yetcites [55] Ferlazzo, N., Andolina, G., Cannata, A., Costanzo, M.G., Rizzo, V., Currò, M., Ientile, R., and Caccamo, D. (2020). Is Melatonin the Cornucopia of the 21st Century?. Antioxidants, 9. source
- Not checked yetcites [56] Maffei, M.E. (2020). 5-Hydroxytryptophan (5-HTP): Natural Occurrence, Analysis, Biosynthesis, Biotechnology, Physiology and Toxicology. Int. J. Mol. Sci., 22. source
- Not checked yetcites [57] Reiter, 2010, Neurotoxins: Free radical mechanisms and melatonin protection, Curr. Neuropharmacol. source
- Not checked yetcites [58] Brinkmann, 2019, The Aryl Hydrocarbon Receptor (AhR) in the Aging Process: Another Puzzling Role for This Highly Conserved Transcription Factor, Front. Physiol. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Circadian rhythm sleep-wake disorders are either intrinsic or extrinsic.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Many neurological disorders feature elements of the kynurenine pathway of tryptophan, specifically the dysregulation of tryptophan metabolism and subsequent melatonin production.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.4. Kynurenine Pathway, Energy Regulation Stress Response
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This dosing regimen may contribute to the occasional complaints of a paradoxical effect of melatonin supplements on sleep.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Melatonin is both water- and lipid-soluble (‘amphiphilic’); thereby, it can freely flow among all bodily tissues, especially across the selective blood–brain barrier, making it likely one of the most formidable antioxidants within the central nervous system [60].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [60] Escames, 2010, The role of mitochondria in brain aging and the effects of melatonin, Curr. Neuropharmacol. source
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Melatonin supplements can be used therapeutically for both conditions [67].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [67] Auger, 2015, Clinical Practice Guideline for the Treatment of Intrinsic Circadian Rhythm Sleep-Wake Disorders: Advanced Sleep-Wake Phase Disorder (ASWPD), Delayed Sleep-Wake Phase Disorder (DSWPD), Non-24-Hour Sleep-Wake Rhythm Disorder (N24SWD), and Irregular Sleep-Wake Rhythm Disorder (ISWRD). An Update for 2015: An American Academy of Sleep Medicine Clinical Practice Guideline, J. Clin. Sleep Med. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Studies using melatonin have explored how shift work, particularly night work with its exposure to light at night, may increase the risk of cancer, aggravate both gastrointestinal and cardiovascular disease, complicate pregnancy, and interfere with drug therapy [68].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [68] Iguichi, 1982, Age-dependent reduction in serum melatonin concentrations in healthy human subjects, J. Clin. Endocrinol. Metab. source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“The AhR is responsible for modulating mitochondrial metabolism, melatonergic pathways, acetyl-coenzyme A, and COX-2 prostaglandin.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.4. Kynurenine Pathway, Energy Regulation Stress Response
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“The melatonin-serotonin pathway accounts for approximately five percent of dietary tryptophan degradation, while the kynurenic pathway accounts for approximately 95 percent of dietary tryptophan degradation [32,56].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.4. Kynurenine Pathway, Energy Regulation Stress Response
What the sources say
- Not checked yetcites [32] Chitimus, D.M., Popescu, M.R., Voiculescu, S.E., Panaitescu, A.M., Pavel, B., Zagrean, L., and Zagrean, A.M. (2020). Melatonin’s Impact on Antioxidative and Anti-Inflammatory Reprogramming in Homeostasis and Disease. Biomolecules, 10. source
- Not checked yetcites [56] Maffei, M.E. (2020). 5-Hydroxytryptophan (5-HTP): Natural Occurrence, Analysis, Biosynthesis, Biotechnology, Physiology and Toxicology. Int. J. Mol. Sci., 22. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“The summary concluded that melatonin is indicated for the following [92]:Insomnia: Immediate release 1–3 mg, 30 min before bed; slow-release can be used for sleep maintenance problemsRegulating sleep in blind individuals who often experience non-24 h sleep-wake rhythm disorder;Replicating the normal endogenous pattern;Delayed sleep phase.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [92] Auld, 2017, Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders, Sleep Med. Rev. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Dysfunctional sleep does not have one mechanism, such as reduced melatonin, but potentially several causes, some or all, may be impacting melatonin levels.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Relatively smaller amounts of melatonin are produced in the retina compared with the pineal gland [96].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [96] Ostrin, 2019, Ocular and systemic melatonin and the influence of light exposure, Clin. Exp. Optom. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Importantly, iRBD is a prodrome biomarker for Parkinson’s disease.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Thus, at a larger, more macroscopic level, as mentioned previously, imbalances in melatonin may be associated with what might be referred to as a “darkness deficiency,” or a lack of adequate evening darkness to initiate the secretion of melatonin by the pineal gland.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“However, interest has been expressed for inflammatory conditions such as ocular neuritis and uveitis [97].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [97] Aranda, 2017, Melatonin as a Therapeutic Resource for Inflammatory Visual Diseases, Curr. Neuropharmacol. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Many studies support melatonin’s use in reducing the ill effects of jet lag and speeding up the normalization of circadian rhythms [73].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [73] Srinivasan, 2008, Jet lag: Therapeutic use of melatonin and possible application of melatonin analogs, Travel. Med. Infect. Dis. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Patients with iRBD will retain muscle tone during REM sleep and can act out their dreams, posing a danger to themselves and others.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: unclear — It is unclear why the paper says it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Moreover, there may be an association between environmental toxins such as heavy metals (e.g., arsenic) and sleep disturbance [82,83].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [82] Rahman, 2022, Association of urinary arsenic and sleep disorder in the US population: NHANES 2015-2016, Environ. Sci. Pollut. Res. Int. source
- Not checked yetcites [83] Shiue, 2017, Urinary arsenic, pesticides, heavy metals, phthalates, polyaromatic hydrocarbons, and polyfluoroalkyl compounds are associated with sleep troubles in adults: USA NHANES, 2005-2006, Environ. Sci. Pollut. Res. Int. source
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“Some researchers suggest that glaucoma may be a therapeutic target for melatonin [98,99].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [98] Martínez-Águila, A., Martín-Gil, A., Carpena-Torres, C., Pastrana, C., and Carracedo, G. (2021). Influence of Circadian Rhythm in the Eye: Significance of Melatonin in Glaucoma. Biomolecules, 11. source
- Not checked yetcites [99] Gubin, 2022, Melatonin, circadian rhythms and glaucoma: Current perspective, Neural Regen. Res. source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Overall, children diagnosed with ASD and positive family history had higher serum melatonin and nitric oxide levels, with significantly lower malondialdehyde/melatonin ratios, suggesting greater impaired oxidant-antioxidant metabolism and balance in children with ASD [117].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [117] Rana, 2021, The Assessment and Treatment of Sleep Abnormalities in Children and Adolescents with Autism Spectrum Disorder: A Review, J. Can. Acad. Child Adolesc. Psychiatry
hedgedcorrelationaln = 103- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Overall, clinical data suggest that melatonin supplementation improves sleep and neurotransmission and reduces sundowning in those with Alzheimer’s disease.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In a systematic review and meta-analysis of thirteen clinical trials, melatonin supplementation was found to decrease inflammatory compounds (TNF-alpha, IL-6, C-reactive protein), although with a more significant lowering effect on TNF-alpha and IL-6, especially with studies ≥ twelve weeks and at a dosage ≥ 10 mg/day [175].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.5. (Auto)Immunity
What the sources say
- Not checked yetcites [175] Zarezadeh, 2020, Melatonin supplementation and pro-inflammatory mediators: A systematic review and meta-analysis of clinical trials, Eur. J. Nutr. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Moreover, with the indole structure of melatonin closely resembling that of tryptophan, there could be theoretical safety concerns related to the Eosinophilia-Myalgia Syndrome (EMS) outbreak in 1989 from the intake of at least six contaminants in an L-tryptophan dietary supplement [264,265,266], although the dose of melatonin tends to be about 1000 times lower than that of tryptophan.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.2. Dietary Supplements
What the sources say
- Not checked yetcites [264] Williamson, 1997, Contaminants in commercial preparations of melatonin, Mayo Clin. Proc. source
- Not checked yetcites [265] Williamson, 1998, Structural characterization of contaminants found in commercial preparations of melatonin: Similarities to case-related compounds from L-tryptophan associated with eosinophilia-myalgia syndrome, Chem. Res. Toxicol. source
- Not checked yetcites [266] Allen, 2011, Post-epidemic eosinophilia-myalgia syndrome associated with L-tryptophan, Arthritis Rheum. source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“It was found that autistic patients have low melatonin levels caused by a primary deficit in ASMT gene activity [116].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [116] Melke, 2008, Abnormal melatonin synthesis in autism spectrum disorders, Mol. Psychiatry source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Age-related macular degeneration is another serious ophthalmic condition that theoretically could benefit from melatonin administration, although significant clinical research is currently lacking [100,101].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [100] Rastmanesh, 2011, Potential of melatonin to treat or prevent age-related macular degeneration through stimulation of telomerase activity, Med. Hypotheses source
- Not checked yetcites [101] Mehrzadi, 2020, Mitochondrial dysfunction in age-related macular degeneration: Melatonin as a potential treatment, Expert Opin. Ther. Targets source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“Most notable is early research conducted on patients with solid metastatic tumors, in which it was demonstrated that high doses of melatonin were effective in arresting tumor growth and improving quality of life markers [178].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.5. (Auto)Immunity
What the sources say
- Not checked yetcites [178] Lissoni, 1991, Clinical results with the pineal hormone melatonin in advanced cancer resistant to standard antitumor therapies, Oncology source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“At a mechanistic level, it may decrease the progression of the disease through its protection of neuronal cells from amyloid-beta, possibly due to the facilitation of its degradation and transport from the brain matter through the glymphatic fluid [102,103,104].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [102] Lin, 2013, Melatonin in Alzheimer’s disease, Int. J. Mol. Sci. source
- Not checked yetcites [103] Roy, J., Tsui, K.C., Ng, J., Fung, M.L., and Lim, L.W. (2021). Regulation of Melatonin and Neurotransmission in Alzheimer’s Disease. Int. J. Mol. Sci., 22. source
- Not checked yetcites [104] Li, 2020, Melatonin regulates Aβ production/clearance balance and Aβ neurotoxicity: A potential therapeutic molecule for Alzheimer’s disease, Biomed. Pharmacother. source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Migraines can also be correlated with many autoimmune disorders tied to melatonin regulation failure. These conditions include Hashimoto’s thyroiditis with associated hypothyroidism, rheumatic diseases, and antiphospholipid syndrome [109].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [109] Ribeiro, 2016, Randomised clinical trial comparing melatonin 3 mg, amitriptyline 25 mg and placebo for migraine prevention, J. Neurol. Neurosurg. Psychiatry source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Migraine headaches are comorbid with several health conditions, including neurological, psychiatric, cardiovascular, cerebrovascular, GI, metaboloendocrine, and immunological disorders.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“A review article found that patients with autism had improved sleep parameters, better daytime behavior, and minimal side effects with melatonin use [118].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [118] Rossignol, 2011, Melatonin in autism spectrum disorders: A systematic review and meta-analysis, Dev. Med. Child. Neurol. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“For jet lag, recent studies are lacking in detailing the most efficacious dose.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Melatonin may not be effective for everyone but could be well-suited for those individuals with a history of jet lag and/or for those flying across ≥ five time zones to the East [74].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [74] Herxheimer, 2002, Melatonin for the prevention and treatment of jet lag, Cochrane Database Syst. Rev.
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: Melatonin may not be effective for everyone.
In the paper
“There have also been reports of vivid dreams or nightmares while using melatonin supplements [164].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [164] Siah, 2014, Melatonin for the treatment of irritable bowel syndrome, World J. Gastroenterol. source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Interestingly, the control group (not insomniacs) also had low melatonin levels, but melatonin did not improve sleep.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [278] Zhdanova, 2001, Melatonin treatment for age-related insomnia, J. Clin. Endocrinol. Metab. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“They concluded that that too much melatonin may negatively affect the melatonin phase-response curve [281].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [281] Lewy, 2002, Low, but not high, doses of melatonin entrained a free-running blind person with a long circadian period, Chronobiol. Int. source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
None of the sources cited for this claim have been checked yet.
In the paper
“Some studies used a protocol in which melatonin supplementation was initiated three days before travel started [284,285].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“The pharmacological dose (3 mg), like the lowest dose (0.1 mg), also improved sleep; however, it induced hypothermia and caused plasma melatonin to remain elevated into the daylight hours.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [278] Zhdanova, 2001, Melatonin treatment for age-related insomnia, J. Clin. Endocrinol. Metab. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Much has been written about melatonin’s therapeutic value, but the doses used in studies tended to be supraphysiological or based on previous studies that did not have an explicit rationale for choosing the amount.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds. It may state two separate claims as one.
In the paper
“The dose of melatonin was patented up to 1 mg based on this earlier research [279], excluding dietary supplement manufacturers from selling this dose and thus, using higher doses.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [279] (1995). National Center for Biotechnology Information. Methods of Inducing Sleep Using Melatonin. (US5449683A), U.S. Patent.
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Melatonin’s action of lowering body temperature is important to monitor and may give significant clues to the appropriate dosage.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In clinical applications, too much melatonin or various extended-release formats have been documented to produce side effects such as amnesia or a “melatonin hangover” the next day, finding it harder to fall asleep, or sleeping well for three to four hours and then waking up and not being able to go back to sleep [275].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [275] Benedict, 2022, Melatonin’s Potential Side Effects: It May Be in Your Genes, Mayo Clin. Proc. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“The physiological dose (0.3 mg) restored sleep efficiency and elevated plasma melatonin levels to normal during early adulthood.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [278] Zhdanova, 2001, Melatonin treatment for age-related insomnia, J. Clin. Endocrinol. Metab. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Although more research is needed comparing synthetic and plant-based sources of melatonin, there is some initial indication that phytomelatonin may have advantages related to improved bioavailability and efficacy.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.2. Dietary Supplements
What the sources say
- Not checked yetcites [34] Kukula-Koch, W., Szwajgier, D., Gaweł-Bęben, K., Strzępek-Gomółka, M., Głowniak, K., and Meissner, H.O. (2021). Is Phytomelatonin Complex Better Than Synthetic Melatonin? The Assessment of the Antiradical and Anti-Inflammatory Properties. Molecules, 26. source
- Not checked yetcites [267] Pérez-Llamas, F., Hernández-Ruiz, J., Cuesta, A., Zamora, S., and Arnao, M.B. (2020). Development of a Phytomelatonin-Rich Extract from Cultured Plants with Excellent Biochemical and Functional Properties as an Alternative to Synthetic Melatonin. Antioxidants, 9. source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“While a theoretical concern, there is a lack of significant scientific evidence that this dependence can develop, and if it does, under which conditions and individuals may be most susceptible.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Lissoni et al.’s cancer research from over twenty years ago demonstrated that 20 mg given intramuscularly followed by oral daily doses of 10 mg was effective in arresting tumor growth and improving quality of life markers [178].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [178] Lissoni, 1991, Clinical results with the pineal hormone melatonin in advanced cancer resistant to standard antitumor therapies, Oncology source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“This pharmaceutical is a known inhibitor of CYP1A2 and can result in the potentiation of melatonin levels due to reducing its degradation [304].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.6. Contraindications and Combinations
What the sources say
- Not checked yetcites [304] Wang, 2001, Differential effects of fluvoxamine and other antidepressants on the biotransformation of melatonin, J. Clin. Psychopharmacol. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In summary, while not a comprehensive listing, melatonin can interact or be influenced by pharmaceuticals, nutrients, or herbs with blood thinning, blood sugar-lowering, blood pressure reducing, anti-convulsing, sedative, anti-depressant, and/or immunosuppressive activities [306].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.6. Contraindications and Combinations
What the sources say
- Not checked yetcites [306] Therapeutic Research (2022, July 31). Melatonin. Available online: https://naturalmedicines.therapeuticresearch.com/.
plainconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“A few human clinical studies published more than two decades ago would suggest that vitamin B12 supplementation increased the phase advance effect of morning light and decreased nocturnal melatonin levels [309,310]”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.6. Contraindications and Combinations
What the sources say
- Not checked yetcites [309] Honma, 1992, Effects of vitamin B12 on plasma melatonin rhythm in humans: Increased light sensitivity phase-advances the circadian clock?, Experientia source
- Not checked yetcites [310] Hashimoto, 1996, Vitamin B12 enhances the phase-response of circadian melatonin rhythm to a single bright light exposure in humans, Neurosci. Lett. source
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Neither the parents nor children monitored their melatonin use but relied on the initial study proposal, so dosing varied widely.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [290] Hoebert, 2009, Long-term follow-up of melatonin treatment in children with ADHD and chronic sleep onset insomnia, J. Pineal Res. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“As stated above, combining melatonin supplementation with actives that influence melatonin pharmacokinetics may cause side effects.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.6. Contraindications and Combinations
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
In the paper
“In one report, clinicians observed that the initial response to melatonin had disappeared weeks after starting treatment, and that the favorable response returned with dose reduction [293].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [293] Braam, 2010, Loss of response to melatonin treatment is associated with slow melatonin metabolism, J. Intellect. Disabil. Res. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Historically, much of the research related to sleep has indicated melatonin supplementation thirty to sixty minutes before bed; yet, some studies have shown that it can be taken up to four hours prior and be effective.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.4. Timing
plainconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“In an average of 3.7 years of follow-up from previous clinical trial participation of pharmacological doses of melatonin, 65% of children were still using melatonin as prescribed in the study, but only 9% were able to discontinue use [290].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [290] Hoebert, 2009, Long-term follow-up of melatonin treatment in children with ADHD and chronic sleep onset insomnia, J. Pineal Res. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Compliance nearly four years later was at 65%, presumably due to the satisfaction of use.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [290] Hoebert, 2009, Long-term follow-up of melatonin treatment in children with ADHD and chronic sleep onset insomnia, J. Pineal Res. source
plainconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Only one questionnaire-based study investigated long-term melatonin use in children with ADHD and chronic insomnia and, by its design, was based on subjective symptom reports.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [290] Hoebert, 2009, Long-term follow-up of melatonin treatment in children with ADHD and chronic sleep onset insomnia, J. Pineal Res. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Lewy suggests that dosing for sleep requires a minimum of twelve hours of wakefulness [281].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.4. Timing
What the sources say
- Not checked yetcites [281] Lewy, 2002, Low, but not high, doses of melatonin entrained a free-running blind person with a long circadian period, Chronobiol. Int. source
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“The authors would like to emphasize that the dramatic increase in the use of supplemental melatonin in children is unwarranted because they endogenously produce more melatonin than adults [10].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [10] Grivas, 2007, Melatonin the “light of night” in human biology and adolescent idiopathic scoliosis, Scoliosis source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“It is well accepted that melatonin in tablet or capsule form is generally not very bioavailable (1 to 74%) and can be influenced by multiple variables [295].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.5. Bioavailability
What the sources say
- Not checked yetcites [295] Savage, R.A., Zafar, N., Yohannan, S., and Miller, J.M.M. (2022). Melatonin. StatPearls, StatPearls Publishing LLC.. StatPearls Publishing. Copyright © 2022.
boostedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“From a pharmacokinetic standpoint, Vasey, McBride, and Penta [297] indicated that melatonin administered in tablet or capsule forms follows first-order or concentration-dependent kinetics. This implies that the kinetic absorption of melatonin is, in fact, not saturable, meaning that larger doses would produce higher plasma concentrations.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.5. Bioavailability
What the sources say
- Not checked yetcites [297] Vasey, C., McBride, J., and Penta, K. (2021). Circadian Rhythm Dysregulation and Restoration: The Role of Melatonin. Nutrients, 13. source
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Dyssomnia, ADHD, and ASD have been studied and reviewed, all confirming effectiveness and safety of melatonin.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: unclear — It is unclear why the paper says it holds.
It may state two separate claims as one. The quote only partly states this claim.
In the paper
“Oral melatonin has been studied to reach peak plasma concentration after forty-one minutes of administration, although it was reported that melatonin pharmacokinetics varied greatly between individuals [297].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.5. Bioavailability
What the sources say
- Not checked yetcites [297] Vasey, C., McBride, J., and Penta, K. (2021). Circadian Rhythm Dysregulation and Restoration: The Role of Melatonin. Nutrients, 13. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“A systematic review by researchers at the University of Copenhagen cited an average of 15% bioavailability from oral melatonin, which was highly variable (range: 9–33%) and affected by age, illness, caffeine, smoking, and medications [296].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.5. Bioavailability
What the sources say
- Not checked yetcites [296] Andersen, 2015, Clinical pharmacokinetics of melatonin: A systematic review, Eur. J. Clin. Pharmacol. source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Historically, due to the lack of safety data, melatonin supplementation was not recommended for women who are pregnant or nursing.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.6. Contraindications and Combinations
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Similarly, caffeine is also metabolized through CYP1A2 and can increase melatonin levels [305].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.6. Contraindications and Combinations
What the sources say
- Not checked yetcites [305] Ursing, 2003, Caffeine raises the serum melatonin level in healthy subjects: An indication of melatonin metabolism by cytochrome P450(CYP)1A2, J. Endocrinol. Investig. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“It should be noted that studies were of various lengths, with some as short as two weeks, and the longest-lasting study was six months.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Indiscriminate, long-term dosing may lead to unnecessary dependence and even perturbations in puberty onset when nocturnal levels of melatonin tend to decline [291].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [291] Boafo, 2019, Could long-term administration of melatonin to prepubertal children affect timing of puberty? A clinician’s perspective, Nat. Sci. Sleep source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“and in the case of methylcobalamin specifically, may even result in less need for sleep and impart better sleep quality [311]”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.6. Contraindications and Combinations
What the sources say
- Not checked yetcites [311] Mayer, 1996, Effects of vitamin B12 on performance and circadian rhythm in normal subjects, Neuropsychopharmacology source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“Other factors: Season, physical activity, age, gender, genetic factors related to the volume of the active pineal gland, and possibly posture at the time of sample collection may all influence melatonin levels [323].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.8. A Comprehensive Clinical Approach to Melatonin
What the sources say
- Not checked yetcites [323] Rzepka-Migut, B., and Paprocka, J. (2020). Melatonin-Measurement Methods and the Factors Modifying the Results. A Systematic Review of the Literature. Int. J. Environ. Res. Public Health, 17. source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Furthermore, the timing of eating and time of sleep may influence melatonin levels, as can intermittent fasting.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.8. A Comprehensive Clinical Approach to Melatonin
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“It has been shown to have systemic effects through its mechanisms of action, ultimately having the potential for a significant impact on the etiologies of multiple chronic diseases.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 5. Conclusions
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“When worn during a 60 min light pulse at 0100 h, blue-light-blocking glasses resulted in a slight increase in melatonin levels compared to baseline, while melatonin levels decreased significantly by 46% in the control condition [320].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.7. Lifestyle Aspects
What the sources say
- Not checked yetcites [320] Bennett, 2009, Use of modified spectacles and light bulbs to block blue light at night may prevent postpartum depression, Med. Hypotheses source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“When it comes to supplemental sources, phytomelatonin may have greater efficacy and present a more sustainable, low-toxic option compared with synthetic formats of melatonin.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 5. Conclusions
What the sources say
- Not checked yetcites [34] Kukula-Koch, W., Szwajgier, D., Gaweł-Bęben, K., Strzępek-Gomółka, M., Głowniak, K., and Meissner, H.O. (2021). Is Phytomelatonin Complex Better Than Synthetic Melatonin? The Assessment of the Antiradical and Anti-Inflammatory Properties. Molecules, 26. source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“In healthy adults without sleep or circadian disorders, using blue-light-blocking glasses from 1800 h until bedtime for a week resulted in subjective reports of earlier sleep onset, though objective measures were not improved.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.7. Lifestyle Aspects
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“One recent clinical trial in type 2 diabetics found that modest vitamin D supplementation helped to increase both vitamin D and glutathione levels, while decreasing oxidative stress and inflammation [317].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.6. Contraindications and Combinations
What the sources say
- Not checked yetcites [317] Gu, 2022, Effect of vitamin D on oxidative stress and serum inflammatory factors in the patients with type 2 diabetes, J. Clin. Lab. Anal. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Finally, lifestyle habits such as proper exposure to light and darkness and less blue light at night are also helpful for establishing healthy melatonin levels.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 5. Conclusions
plainconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“It remains unclear how food intake (types of foods, macronutrient distribution, timing) during the day can alter pineal gland secretion of melatonin at night;”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.8. A Comprehensive Clinical Approach to Melatonin
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“After seven nights of wearing blue blockers for two hours before bed, people with insomnia have significantly improved subjective and objective total sleep time, sleep quality, and soundness [321].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.7. Lifestyle Aspects
What the sources say
- Not checked yetcites [321] Shechter, 2018, Blocking nocturnal blue light for insomnia: A randomized controlled trial, J. Psychiatr. Res. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“From a scientific perspective, melatonin acts as a powerful antioxidant that can cross the blood–brain barrier, inhibit inflammation, and interact with the gut microbiome.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 5. Conclusions
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper may give no reason why it holds. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Thus, while not yet extensively researched, there could be an interrelationship between the collective antioxidant activities of glutathione, vitamin D, and melatonin.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.6. Contraindications and Combinations
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“For people with Delayed Sleep-Wake Phase, wearing blue-light-blocking glasses from 2100 h to bedtime for two weeks resulted in their dim-light melatonin onset occurring 78 min earlier, while sleep onset was significantly earlier by 132 min [322].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.7. Lifestyle Aspects
What the sources say
- Not checked yetcites [322] Esaki, 2016, Wearing blue light-blocking glasses in the evening advances circadian rhythms in the patients with delayed sleep phase disorder: An open-label trial, Chronobiol. Int. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Various research studies have confirmed that there are individual associations between melatonin and glutathione [165], and glutathione and vitamin D [316].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.6. Contraindications and Combinations
What the sources say
- Not checked yetcites [165] Muñoz-Jurado, A., Escribano, B.M., Caballero-Villarraso, J., Galván, A., Agüera, E., Santamaría, A., and Túnez, I. (2022). Melatonin and multiple sclerosis: Antioxidant, anti-inflammatory and immunomodulator mechanism of action. Inflammopharmacology, 1–28. source
- Not checked yetcites [316] Parsanathan, 2019, Glutathione deficiency induces epigenetic alterations of vitamin D metabolism genes in the livers of high-fat diet-fed obese mice, Sci. Rep. source
boostedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“To reduce the risk of inaccuracies, the patient would at least need to abstain from dietary sources of melatonin; however, this is not always practical, and many foods contain melatonin.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.8. A Comprehensive Clinical Approach to Melatonin
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Routine laboratories do not tend to offer this type of testing, and of the specialty labs that offer these assessments, there are some confounding factors to consider:”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.8. A Comprehensive Clinical Approach to Melatonin
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
- Rests on an assumption: Routine laboratories do not tend to offer melatonin testing.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“From a clinical point of view, melatonin imbalance may indicate “darkness deficiency” in much the same way that vitamin D may infer whether or not someone has a “light deficiency”.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 5. Conclusions
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: fails — It may be too vague to check against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. It may be too vague to check against evidence. The paper may give no reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Light exposure: Results will be variable and potentially influenced by light conditions. Since melatonin is strongly suppressed by light, the test will not yield many useful data in people’s normal home lighting. It will simply reflect the suppressed levels expected in electric lighting.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.8. A Comprehensive Clinical Approach to Melatonin
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: The circadian release of melatonin is strongly suppressed by light, particularly blue light.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Overall, melatonin is an intriguing compound, not unlike vitamin D, which is pleiotropic in activity and responsive to light-dark cycles.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 5. Conclusions
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: fails — It may be too vague to check against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. It may be too vague to check against evidence. It may state two separate claims as one.
In the paper
“Glutathione is one of the major antioxidant systems in the body and is susceptible to changes in redox status and nutrient supply [315].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.6. Contraindications and Combinations
What the sources say
- Not checked yetcites [315] Minich, D.M., and Brown, B.I. (2019). A Review of Dietary (Phyto)Nutrients for Glutathione Support. Nutrients, 11. source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
The paper relies on this without support.
Oxidative stress is one of the leading causes of age-related brain dysfunction by impairing neurogenesis.
“Oxidative stress is one of the leading causes of age-related brain dysfunction by impairing neurogenesis.”
The paper relies on this without support.
The purity of a melatonin dietary supplement available to most consumers on the retail store shelf may be debatable or simply unknown without greater diligence to investigate the source.
“Thus, the purity of a melatonin dietary supplement available to most consumers on the retail store shelf may be debatable or simply unknown without greater diligence to investigate the source, which is often cumbersome and time-consuming.”
The paper relies on this without support.
Larger doses of melatonin do not always confer greater health benefits.
“Larger doses do not always confer greater health benefits.”
The paper relies on this without support.
The upper limits of a lethal dose of melatonin have not been clinically established.
“The upper limits of a lethal dose of melatonin have not been clinically established.”
The paper relies on this without support.
Melatonin is quickly broken down by the body.
“Melatonin is quickly broken down by the body and should be dosed at the appropriate, personalized level for each patient.”
The paper relies on this without support.
Melatonin may not be effective for everyone.
“Melatonin may not be effective for everyone but could be well-suited for those individuals with a history of jet lag and/or for those flying across ≥ five time zones to the East [74].”
The paper relies on this without support.
There is some indication that melatonin may be of benefit during pregnancy and nursing.
“However, there is some indication that melatonin may be of benefit during both these stages.”
The paper relies on this without support.
In certain instances, nutrients may be more effective when included with melatonin or vice versa.
“Conversely, in certain instances, nutrients may be more effective when included with melatonin or vice versa.”
The paper relies on this without support.
Type 2 diabetics may be particularly vulnerable to decreases in antioxidants and increases in inflammatory markers.
“Type 2 diabetics may be particularly vulnerable to decreases in antioxidants and increases in inflammatory markers.”
The paper relies on this without support.
The circadian release of melatonin is strongly suppressed by light, particularly blue light.
“The circadian release of melatonin is strongly suppressed by light, particularly blue light.”
The paper relies on this without support.
Assessing one's levels of systemic melatonin is difficult.
“From a clinical perspective, assessing one’s levels of systemic melatonin is difficult.”
The paper relies on this without support.
Routine laboratories do not tend to offer melatonin testing.
“Routine laboratories do not tend to offer this type of testing”
The paper relies on this without support.
Melatonin has been misunderstood as a sleep aid.
“To some extent, melatonin has been misunderstood as a sleep aid.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Melatonin acts together with vitamin D as “light sensors” to meet the requirements for light and dark (Minich et al. 2022).”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Minich et al. 2022
In the citing paper
“Interestingly, in 2020–2021, during the COVID-19 pandemic period, melatonin was the most sought-after supplement to optimize levels of cytokines linked with disturbed sleeping (Minich et al. 2022).”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Minich et al. 2022
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“a 50 km (31 m) course”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.5. (Auto)Immunity
Reported 31 · recomputed 50000
Citations
Cites
1 retracted
Pacchiarotti, A., Carlomagno, G., Antonini, G., & Pacchiarotti, A. (2016) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1101444 · Cited by 111
RetractedThe National Center for Biotechnology Information
Benson, D. A., Boguski, M. S., Lipman, D. J., & Ostell, J. (1990) · Genomics · doi:10.1016/0888-7543(90)90583-g · Cited by 5,109
Ighodaro, O. M., & Akinloye, O. A. (2017) · Alexandria Journal of Medicine · doi:10.1016/j.ajme.2017.09.001 · Cited by 4,036 · cited 2×
“Notably, as stated above, it is a highly efficient antioxidant as one molecule of melatonin can scavenge multiple (~10) reactive oxygen and nitrogen species through a cascading mechanism related to its secondary, tertiary, and even quaternary metabolites [24,31].”
BackgroundInternational Classification of Sleep Disorders-Third Edition
Sateia, M. J. (2014) · Chest · doi:10.1378/chest.14-0970 · Cited by 3,860
Tan, D., Manchester, L. C., Terron, M. P., Flores, L. J., & Reiter, R. J. (2007) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2006.00407.x · Cited by 1,601 · cited 3×
“Phytomelatonin was found to have 646% stronger COX-2 inhibition (see Figure 4), 267–470% more potent free-radical scavenging ability (see Figure 5), and 100% greater efficacy in reducing cellular ROS in a human skin cell line (see Figure 6) when compared to synthetic melatonin, most likely due to the other constituent…”
BackgroundHealth disorders of shift workers
Knutsson, A. (2003) · Occupational Medicine · doi:10.1093/occmed/kqg048 · Cited by 1,218
Sunlight and Vitamin D: A global perspective for health
Wacker, M., & Holick, M. F. (2013) · Dermato-Endocrinology · doi:10.4161/derm.24494 · Cited by 1,156
Dubbels, R., Reiter, R. J., Klenke, E., Goebel, A., Schnakenberg, E., Ehlers, C., SCHIWARA, H. W., & Schloot, W. (1995) · Journal of Pineal Research · doi:10.1111/j.1600-079x.1995.tb00136.x · Cited by 1,104
The 2022 hormone therapy position statement of The North American Menopause Society
(2022) · Menopause · doi:10.1097/gme.0000000000002028 · Cited by 977
Melatonin: Nature’s most versatile biological signal?
Pandi‐Perumal, S. R., Srinivasan, V., Maestroni, G. J. M., Cardinali, D. P., Poeggeler, B., & Hardeland, R. (2006) · The FEBS Journal · doi:10.1111/j.1742-4658.2006.05322.x · Cited by 875 · cited 10×
“Production gradually declines as people age, starting in the late twenties to the fifties, with production leveling at approximately 30 pg/mL [4,11] (see Figure 1).”
BackgroundInfluentialAn American Academy of Sleep Medicine Report, Morgenthaler, T., Kramer, M., Alessi, C., Friedman, L., Boehlecke, B., Brown, T., Coleman, J., Kapur, V., Lee-Chiong, T., et al. (2006) · Sleep · doi:10.1093/sleep/29.11.1415 · Cited by 835 · cited 1×
“Sleep hygiene, such as room temperature, adequate darkness, noise, and comfort of bed and pillows, would be simple actions to ensure a healthy environment [84,85].”
BackgroundHattori, A., Migitaka, H., Iigo, M., Itoh, M., Yamamoto, K., Ohtani‐Kaneko, R., Hara, M., Suzuki, T., & Reiter, R. J. (1995) · PubMed · Cited by 827
Melatonin as a Potent and Inducible Endogenous Antioxidant: Synthesis and Metabolism
Tan, D.-X., Manchester, L., Esteban-Zubero, E., Zhou, Z., & Reiter, R. (2015) · Molecules · doi:10.3390/molecules201018886 · Cited by 719 · cited 3×
“Finally, melatonin is involved with multiple activities that include mitochondrial homeostasis, genomic regulation, modulation of inflammatory and immune cytokines, directly impacting both systemic and acute anti-inflammatory properties as well as indications around its potential role in phase separation [25,26].”
BackgroundSleep deficiency and chronic pain: potential underlying mechanisms and clinical implications
Haack, M., Simpson, N. S., Sethna, N. F., Kaur, S., & Mullington, J. M. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0439-z · Cited by 696 · cited 1×
“Underlying inflammation-related diseases may need to be addressed, such as metabolic syndrome, sleep apnea, and any type of joint or muscle pain [77,78].”
BackgroundBrown, T. M., Brainard, G. C., Cajochen, C., Czeisler, C. A., Hanifin, J. P., Lockley, S. W., Lucas, R. J., Münch, M., O’Hagan, J. B., Peirson, S. N., et al. (2022) · PLOS Biology · doi:10.1371/journal.pbio.3001571 · Cited by 659 · cited 1×
“Sleep hygiene, such as room temperature, adequate darkness, noise, and comfort of bed and pillows, would be simple actions to ensure a healthy environment [84,85].”
BackgroundPractice Parameters for the Clinical Evaluation and Treatment of Circadian Rhythm Sleep Disorders
Morgenthaler, T. I., Lee-Chiong, T., Alessi, C., Friedman, L., Aurora, R. N., Boehlecke, B., Brown, T., Chesson, A. L., Kapur, V., Maganti, R., et al. (2007) · Sleep · doi:10.1093/sleep/30.11.1445 · Cited by 629
Sleep health: Reciprocal regulation of sleep and innate immunity
Irwin, M. R., & Opp, M. R. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.148 · Cited by 624 · cited 1×
“Underlying inflammation-related diseases may need to be addressed, such as metabolic syndrome, sleep apnea, and any type of joint or muscle pain [77,78].”
BackgroundBouatia-Naji, N., Bonnefond, A., Cavalcanti-Proença, C., Sparsø, T., Holmkvist, J., Marchand, M., Delplanque, J., Lobbens, S., Rocheleau, G., Durand, E., et al. (2009) · Nature Genetics · doi:10.1038/ng.277 · Cited by 611
Systematic review of light exposure impact on human circadian rhythm
Tähkämö, L., Partonen, T., & Pesonen, A.-K. (2019) · Chronobiology International · doi:10.1080/07420528.2018.1527773 · Cited by 535
Abnormal melatonin synthesis in autism spectrum disorders
Melke, J., Goubran Botros, H., Chaste, P., Betancur, C., Nygren, G., Anckarsäter, H., Rastam, M., Ståhlberg, O., Gillberg, I. C., Delorme, R., et al. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002016 · Cited by 511 · cited 1×
“It was found that autistic patients have low melatonin levels caused by a primary deficit in ASMT gene activity [117].”
BackgroundMeta-Analysis: Melatonin for the Treatment of Primary Sleep Disorders
Ferracioli-Oda, E., Qawasmi, A., & Bloch, M. H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063773 · Cited by 493 · cited 1×
“Trials that used higher doses of melatonin and conducted over a longer duration demonstrated even greater effects on these two sleep issues, and overall sleep quality was also significantly improved in melatonin users [1,91].”
BackgroundEntrainment of free-running circadian rhythms by melatonin in blind people
Sack, R. L., Brandes, R. W., Kendall, A. R., & Lewy, A. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010123431503 · Cited by 490
Melatonin in autism spectrum disorders: a systematic review and meta-analysis
ROSSIGNOL, D. A., & FRYE, R. E. (2011) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2011.03980.x · Cited by 468 · cited 1×
“A review article found that patients with autism had improved sleep parameters, better daytime behavior, and minimal side effects with melatonin use [119].”
BackgroundSejbuk, M., Mirończuk-Chodakowska, I., & Witkowska, A. M. (2022) · Nutrients · doi:10.3390/nu14091912 · Cited by 458 · cited 2×
“Further to the sleeping room, engaging in healthy lifestyle practices such as refraining from stimulants, eating or being on devices too close to bedtime, and unwinding from the day’s stresses with relaxation practices such as a warm bath or physical activity, need consideration [86,87].”
BackgroundBuscemi, N., Vandermeer, B., Hooton, N., Pandya, R., Tjosvold, L., Hartling, L., Vohra, S., Klassen, T. P., & Baker, G. (2006) · BMJ · doi:10.1136/bmj.38731.532766.f6 · Cited by 454
Auger, R. R., Burgess, H. J., Emens, J. S., Deriy, L. V., Thomas, S. M., & Sharkey, K. M. (2015) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.5100 · Cited by 437 · cited 1×
“Melatonin supplements can be used therapeutically for both conditions [67].”
BackgroundMelatonin for the prevention and treatment of jet lag
Herxheimer, A., & Petrie, K. J. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001520 · Cited by 428 · cited 1×
“In a Cochrane review, nine out of ten trials found that melatonin effectively reduced jet lag symptoms in travelers, especially if traveling eastward or over five time zones [74].”
BackgroundGenetic Basis of Polycystic Ovary Syndrome (PCOS): Current Perspectives
Khan, M. J., Ullah, A., & Basit, S. (2019) · The Application of Clinical Genetics · doi:10.2147/tacg.s200341 · Cited by 412 · cited 1×
“It is a multifactorial disease with increased androgens, hirsutism, acne, insulin resistance, central obesity, amenorrhea or oligomenorrhea, poor sleep, anovulation, and decreased fertility [153].”
BackgroundEvidence for the efficacy of melatonin in the treatment of primary adult sleep disorders
Auld, F., Maschauer, E. L., Morrison, I., Skene, D. J., & Riha, R. L. (2016) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2016.06.005 · Cited by 402 · cited 2×
“The summary concluded that melatonin is indicated for the following [92]:”
BackgroundMitochondria: Central Organelles for Melatonin′s Antioxidant and Anti-Aging Actions
Reiter, R., Tan, D., Rosales-Corral, S., Galano, A., Zhou, X., & Xu, B. (2018) · Molecules · doi:10.3390/molecules23020509 · Cited by 393 · cited 3×
“Mitochondrial dysfunction is one of the mechanisms related to diseases of aging [36].”
BackgroundResultInfluentialAge-Dependent Reduction in Serum Melatonin Concentrations in Healthy Human Subjects
Iguchi, H., Kato, K., & Ibayashi, H. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-55-1-27 · Cited by 381 · cited 1×
“Studies using melatonin have explored how shift work, particularly night work with its exposure to light at night, may increase the risk of cancer, aggravate both gastrointestinal and cardiovascular disease, complicate pregnancy, and interfere with drug therapy [68].”
BackgroundMelatonin in walnuts: Influence on levels of melatonin and total antioxidant capacity of blood
Reiter, R. J., Manchester, L. C., & Tan, D. (2005) · Nutrition · doi:10.1016/j.nut.2005.02.005 · Cited by 372
High levels of melatonin in the seeds of edible plants
Manchester, L. C., Tan, D. X., Reiter, R. J., Park, W., Monis, K., & Qi, W. (2000) · Life Sciences · doi:10.1016/s0024-3205(00)00896-1 · Cited by 367
Dietary Sources and Bioactivities of Melatonin
Meng, X., Li, Y., Li, S., Zhou, Y., Gan, R.-Y., Xu, D.-P., & Li, H.-B. (2017) · Nutrients · doi:10.3390/nu9040367 · Cited by 362 · cited 2×
“It is present in nearly all bodily fluids: cerebrospinal fluid, saliva, bile, synovial fluid, amniotic fluid, urine, feces, semen, and breast milk [16,19,20].”
BackgroundMelatonin’s Impact on Antioxidative and Anti-Inflammatory Reprogramming in Homeostasis and Disease
Chitimus, D. M., Popescu, M. R., Voiculescu, S. E., Panaitescu, A. M., Pavel, B., Zagrean, L., & Zagrean, A.-M. (2020) · Biomolecules · doi:10.3390/biom10091211 · Cited by 354 · cited 6×
“Melatonin is derived from serotonin using 5-hydroxytryptophan (5-HTP) and tryptophan [32,55].”
BackgroundMethodInfluentialCircadian rhythm dysregulation and restoration: the role of melatonin
Vasey, C., McBride, J., & Penta, K. (2021) · Nutrients · doi:10.3390/nu13103480 · Cited by 351
Aging, melatonin, and the pro- and anti-inflammatory networks
Hardeland, R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051223 · Cited by 337 · cited 1×
“In vitro and in vivo studies demonstrate melatonin’s protective ability against mitochondria-mediated injury with hypertension and obesity, suggesting that dietary supplementation with exogenous melatonin in later years may be an effective therapeutic intervention for such age-related conditions [33].”
BackgroundGummin, D. D., Mowry, J. B., Beuhler, M. C., Spyker, D. A., Bronstein, A. C., Rivers, L. J., Pham, N. P. T., & Weber, J. (2021) · Clinical Toxicology · doi:10.1080/15563650.2021.1989785 · Cited by 333
Clinical pharmacokinetics of melatonin: a systematic review
Harpsøe, N. G., Andersen, L. P. H., Gögenür, I., & Rosenberg, J. (2015) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-015-1873-4 · Cited by 329
Melatonin: an inhibitor of breast cancer
Hill, S. M., Belancio, V. P., Dauchy, R. T., Xiang, S., Brimer, S., Mao, L., Hauch, A. T., Lundberg, P. W., Summers, W. M., Yuan, L., et al. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0030 · Cited by 328
Metabolism of melatonin by human cytochromes p450
Ma, X., Idle, J. R., Krausz, K. W., & Gonzalez, F. J. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.002410 · Cited by 319
Melatonin Contributes to the Seasonality of Multiple Sclerosis Relapses
Farez, M. F., Mascanfroni, I. D., Méndez-Huergo, S. P., Yeste, A., Murugaiyan, G., Garo, L. P., Balbuena Aguirre, M. E., Patel, B., Ysrraelit, M. C., Zhu, C., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.025 · Cited by 318 · cited 1×
“Melatonin is linked to the seasonal relapse rate in patients with MS [167].”
BackgroundMelatonin treatment for age-related insomnia
Zhdanova, I. V., Wurtman, R. J., Regan, M. M., Taylor, J. A., Shi, J. P., & Leclair, O. U. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.10.7901 · Cited by 308
Melatonin in Chinese medicinal herbs
Chen, G., Huo, Y., Tan, D., Liang, Z., Zhang, W., & Zhang, Y. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00252-2 · Cited by 306
Koziróg, M., Poliwczak, A. R., Duchnowicz, P., Koter-Michalak, M., Sikora, J., & Broncel, M. (2011) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2010.00835.x · Cited by 299 · cited 1×
“Improvements in LDL cholesterol and blood pressure have been shown in as few as two months of melatonin use (5 mg/day, two hours before bedtime) in thirty patients with documented metabolic syndrome who had not responded to a three-month intervention of therapeutic lifestyle modifications [120].”
BackgroundLutein and Zeaxanthin and Their Roles in Age-Related Macular Degeneration—Neurodegenerative Disease
Mrowicka, M., Mrowicki, J., Kucharska, E., & Majsterek, I. (2022) · Nutrients · doi:10.3390/nu14040827 · Cited by 299
Analysis, Nutrition, and Health Benefits of Tryptophan
Friedman, M. (2018) · International Journal of Tryptophan Research · doi:10.1177/1178646918802282 · Cited by 293
The effects of physical activity on cortisol and sleep: A systematic review and meta-analysis.
De Nys, L., Anderson, K., Ofosu, E. F., Ryde, G. C., Connelly, J., & Whittaker, A. C. (2022) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2022.105843 · Cited by 279
Melatonin and its potential biological functions in the fruits of sweet cherry
Zhao, Y. Q., Tan, D. X., Lei, Q., Chen, H., Wang, L., Li, Q., Gao, Y., & Kong, J. (2013) · Journal of Pineal Research · doi:10.1111/jpi.12044 · Cited by 274
Erland, L. A. E., & Saxena, P. K. (2017) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.6462 · Cited by 273
Olcese, J., Cao, C., Mori, T., Mamcarz, M. B., Maxwell, A. K., Runfeldt, M. J., Wang, L., Zhang, C., Lin, X., Zhang, G., et al. (2009) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2009.00692.x · Cited by 264 · cited 1×
“The sensitive nature of mitochondrial membranes, which can be damaged by many factors, may find protection with the oral administration of melatonin [62].”
BackgroundMelatonin in feverfew and other medicinal plants
Murch, S. J., Simmons, C. B., & Saxena, P. K. (1997) · The Lancet · doi:10.1016/s0140-6736(05)64014-7 · Cited by 256
Distribution, function and physiological role of melatonin in the lower gut
Chen, C.-Q. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i34.3888 · Cited by 255 · cited 3×
“there is 400 times more melatonin in the gut mucosa [5].”
BackgroundEffect of melatonin on jet lag after long haul flights.
Petrie, K. J., Conaglen, J. V., Thompson, L., & Chamberlain, K. (1989) · BMJ · doi:10.1136/bmj.298.6675.705 · Cited by 242
Burkhardt, S., Tan, D. X., Manchester, L. C., Hardeland, R., & Reiter, R. J. (2001) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf010321+ · Cited by 242 · cited 1×
“1 ng of melatonin per gram cherries [215].”
BackgroundMaffei, M. E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010181 · Cited by 236
Melatonin as an anti-inflammatory agent modulating inflammasome activation
Favero, G., Franceschetti, L., Bonomini, F., Rodella, L. F., & Rezzani, R. (2017) · International Journal of Endocrinology · doi:10.1155/2017/1835195 · Cited by 233 · cited 2×
“Recent in vitro and in vivo studies have continued to fortify the foundational aspects established over the past decades that would attest to melatonin’s roles in antioxidant defense, oxidative stress reduction, and anti-inflammatory processes [29,30].”
BackgroundMethylenetetrahydrofolate (MTHFR), the One-Carbon Cycle, and Cardiovascular Risks
Raghubeer, S., & Matsha, T. E. (2021) · Nutrients · doi:10.3390/nu13124562 · Cited by 233
Effect of tart cherry juice (Prunus Cerasus) on melatonin levels and enhanced sleep quality
Howatson, G., Bell, P. G., Tallent, J., Middleton, B., McHugh, M. P., & Ellis, J. (2012) · European Journal of Nutrition · doi:10.1007/s00394-011-0263-7 · Cited by 230
Sleep and Diet: Mounting Evidence of a Cyclical Relationship
Zuraikat, F. M., Wood, R. A., Barragán, R., & St‐Onge, M. (2021) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-120420-021719 · Cited by 230
Melatonin in Alzheimer’s Disease
Li, L., Qiong-xia, H., Yang, S.-S., Chu, J., Wang, J., & Tian, Q. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140714575 · Cited by 229
A Review of Dietary (Phyto)Nutrients for Glutathione Support
Minich, D. M., & Brown, B. I. (2019) · Nutrients · doi:10.3390/nu11092073 · Cited by 225
Self-citationHuman Phase Response Curves to Three Days of Daily Melatonin: 0.5 mg Versus 3.0 mg
Burgess, H. J., Revell, V. L., Molina, T. A., & Eastman, C. I. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2590 · Cited by 221 · cited 1×
“The melatonin phase response curve specifies how exogenous melatonin will shift the individuals’ body clock when given at various times in relation to their sleep midpoint [65].”
BackgroundLong‐term follow‐up of melatonin treatment in children with ADHD and chronic sleep onset insomnia
Hoebert, M., Van Der Heijden, K. B., Van Geijlswijk, I. M., & Smits, M. G. (2009) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2009.00681.x · Cited by 220
Tan, D., Xu, B., Zhou, X., & Reiter, R. (2018) · Molecules · doi:10.3390/molecules23020301 · Cited by 220 · cited 5×
“In fact, it has been suggested to be one of the most potent antioxidants because of its ability to scavenge up to 10 reactive oxygen (ROS) and nitrogen species (RNS) with its metabolites compared with most antioxidants, which may only be able to quench a few ROS [16,23,24].”
BackgroundInfluentialKotlarczyk, M. P., Lassila, H. C., O’Neil, C. K., D'Amico, F. J., Enderby, L. T., Witt‐Enderby, P. A., & Balk, J. L. (2011) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00956.x · Cited by 216
Li, Y., Zhang, J., Wan, J., Liu, A., & Sun, J. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110887 · Cited by 214
A double-blind trial of melatonin as a treatment for jet lag in international cabin crew
Petrie, K. J., Dawson, A. G., Thompson, L., & Brook, R. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90007-z · Cited by 212
Melatonin, Serotonin, and Tryptamine in Some Egyptian Food and Medicinal Plants
Badria, F. A. (2002) · Journal of Medicinal Food · doi:10.1089/10966200260398189 · Cited by 205
Blocking nocturnal blue light for insomnia: A randomized controlled trial
Shechter, A., Kim, E. W., St-Onge, M.-P., & Westwood, A. J. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.10.015 · Cited by 204
Molecular links between endocrine, nervous and immune system during chronic stress
Zefferino, R., Di Gioia, S., & Conese, M. (2021) · Brain and Behavior · doi:10.1002/brb3.1960 · Cited by 204 · cited 1×
“Patients with breast and colorectal cancers were observed to have altered circadian rhythms associated with flattened cortisol levels throughout the day [187].”
BackgroundGitto, E., Tan, D.-X., Reiter, R. J., Karbownik, M., Manchester, L. C., Cuzzocrea, S., Fulia, F., & Barberi, I. (2001) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357011777747 · Cited by 196 · cited 2×
“Phytomelatonin was found to have 646% stronger COX-2 inhibition (see Figure 4), 267–470% more potent free-radical scavenging ability (see Figure 5), and 100% greater efficacy in reducing cellular ROS in a human skin cell line (see Figure 6) when compared to synthetic melatonin, most likely due to the other constituent…”
BackgroundMelatonin in Medicinal and Food Plants: Occurrence, Bioavailability, and Health Potential for Humans
Salehi, B., Sharopov, F. S., Fokou, P. V. T., Kobylińska, A., de Jonge, L., Tadio, K., Sharifi‐Rad, J., Posmyk, M. M., Martorell, M., Martins, N. A., et al. (2019) · Cells · doi:10.3390/cells8070681 · Cited by 189 · cited 2×
“Regardless of its origin and the biosynthetic pathways used to manufacture it, the chemical structure of melatonin in plants and animals is similar and bioidentical to what is found in humans [201].”
BackgroundIs Melatonin the Cornucopia of the 21st Century?
Ferlazzo, N., Andolina, G., Cannata, A., Costanzo, M. G., Rizzo, V., Currò, M., Ientile, R., & Caccamo, D. (2020) · Antioxidants · doi:10.3390/antiox9111088 · Cited by 189 · cited 4×
“Exercise has been found to increase the throughput in the serotonin-melatonin pathway, eventually increasing both serotonin and melatonin levels and impacting mood and cognition [55].”
BackgroundMethodInfluentialTractenberg, R. E., Singer, C. M., Cummings, J. L., & Thal, L. J. (2003) · Journal of Sleep Research · doi:10.1046/j.0962-1105.2003.00374.x · Cited by 188 · cited 1×
“Thus, researchers are exploring influences on monoamine synthesis, a common target for diseases of the aging brain [108,109], as well as the potential of melatonin as a therapeutic in dementia.”
BackgroundSaeteaw, M., Johns, J. R., Johns, N. P., & Subongkot, S. (2012) · Journal of Pineal Research · doi:10.1111/jpi.12025 · Cited by 183 · cited 1×
“In one study with twelve healthy men [208], drinking juice extracted from one kilogram of orange or pineapple or two whole bananas resulted in significant elevations in serum melatonin and increases in antioxidant status (as measured using the FRAP and ORAC analyses).”
MethodPhytomelatonin: Discovery, Content, and Role in Plants
Arnao, M. B. (2014) · Advances in Botany · doi:10.1155/2014/815769 · Cited by 182
Managing Travel Fatigue and Jet Lag in Athletes: A Review and Consensus Statement
van Rensburg, D. C. J., van Rensburg, A. J., Fowler, P., Bender, A. M., Stevens, D. J., Sullivan, K. O., Fullagar, H. H. K., Alonso, J. M., Biggins, M., Claassen-Smithers, A., et al. (2021) · Sports Medicine · doi:10.1007/s40279-021-01502-0 · Cited by 182 · cited 1×
“These protocols are best known by sleep specialists [75].”
BackgroundNeurotoxins: Free radical mechanisms and melatonin protection
J. Reiter, R., C. Manchester, L., & Tan, D.-X. (2010) · Current Neuropharmacology · doi:10.2174/157015910792246236 · Cited by 179
Inflammation-Induced Tryptophan Breakdown is Related With Anemia, Fatigue, and Depression in Cancer
Lanser, L., Kink, P., Egger, E. M., Willenbacher, W., Fuchs, D., Weiß, G., & Kurz, K. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00249 · Cited by 175 · cited 1×
“During this process, the kynurenic pathway is accelerated, causing inflammation-mediated tryptophan catabolism, fatigue, anemia, and depression [191].”
BackgroundOcular and systemic melatonin and the influence of light exposure
Ostrin, L. A. (2018) · Clinical and Experimental Optometry · doi:10.1111/cxo.12824 · Cited by 173 · cited 1×
“Relatively smaller amounts of melatonin are produced in the retina compared with the pineal gland [96].”
BackgroundMitochondria: the birth place, battle ground and the site of melatonin metabolism in cells
Tan, D.-X., & Reiter, R. J. (2019) · Melatonin Research · doi:10.32794/mr11250011 · Cited by 172 · cited 2×
“ewer data indicate that he mitochondria re pivotal for sev ral aspects of melatonin: its production, metabolism, and ctivity through receptors [35].”
BackgroundGonçalves, A. L., Martini Ferreira, A., Ribeiro, R. T., Zukerman, E., Cipolla-Neto, J., & Peres, M. F. P. (2016) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2016-313458 · Cited by 169 · cited 4×
“A 3 mg dose of melatonin reduced migraine frequency, demonstrating the same effectiveness as amitriptyline in the primary endpoint of the frequency of migraine headaches per month [110].”
BackgroundInfluentialPossible therapeutic value of melatonin in mild cognitive impairment: A retrospective study
Furio, A. M., Brusco, L. I., & Cardinali, D. P. (2007) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2007.00491.x · Cited by 167 · cited 1×
“A more extensive, longer-term study found that patients with mild cognitive impairment scored better on the Mini-Mental Status Exam and the Sleep Disorders Index when taking melatonin [107].”
BackgroundWatad, ., Azrielant, S., Bragazzi, N. L., Sharif, Κ., David, P., Katz, I., Aljadeff, G., Quaresma, M., Tanay, G., Adawi, M., et al. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.06.001 · Cited by 167
Stege, P. W., Sombra, L. L., Messina, G. A., Martinez, L. D., & Silva, M. F. (2010) · Electrophoresis · doi:10.1002/elps.200900782 · Cited by 165
Checa-Ros, A., Jeréz-Calero, A., Molina-Carballo, A., Campoy, C., & Muñoz-Hoyos, A. (2021) · Nutrients · doi:10.3390/nu13010249 · Cited by 164 · cited 12×
“In most individuals with ADHD, there is a delayed circadian phase (evening preference) and subsequent issues with daytime function.”
BackgroundInfluentialAmstrup, A. K., Sikjær, T., Heickendorff, L., Mosekilde, L., & Rejnmark, L. (2015) · Journal of Pineal Research · doi:10.1111/jpi.12252 · Cited by 163 · cited 1×
“clinical trials using a relatively small number of study subjects have demonstrated melatonin’s role in rebalancing bone remodeling in perimenopausal women [197] and increasing bone density in postmenopausal women with osteopenia [198].”
BackgroundEffects of a tart cherry juice beverage on the sleep of older adults with insomnia: A pilot study
Pigeon, W. R., Carr, M., Gorman, C., & Perlis, M. L. (2010) · Journal of Medicinal Food · doi:10.1089/jmf.2009.0096 · Cited by 159
Phytomelatonin: an unexpected molecule with amazing performances in plants
Arnao, M. B., Cano, A., & Hernández‐Ruíz, J. (2022) · Journal of Experimental Botany · doi:10.1093/jxb/erac009 · Cited by 158 · cited 1×
“Notably, one of the many roles of melatonin within plants is to stimulate the production of health-promoting phytonutrients like glucosinolates and polyphenols [213].”
BackgroundSchwertner, A., Conceição dos Santos, C. C., Costa, G. D., Deitos, A., de Souza, A., de Souza, I. C. C., Torres, I. L. S., da Cunha Filho, J. S. L., & Caumo, W. (2013) · Pain · doi:10.1016/j.pain.2013.02.025 · Cited by 155 · cited 1×
“found that melatonin at 10 mg nightly reduced endometriosis pain by about 40% and reduced the use of painrelieving medications by 80% over two months [149].”
BackgroundComparative study to determine the optimal melatonin dosage form for the alleviation of jet lag
Suhner, A., Schlagenhauf, P., Johnson, R., Tschopp, A., & Steffen, R. (1998) · Chronobiology International · doi:10.3109/07420529808993201 · Cited by 147
Reiter, R. J., & Tan, D. X. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb02938.x · Cited by 145 · cited 1×
“Melatonin is relatively ubiquitous in nature and can be found widespread in several animal and plant foods [19,200].”
BackgroundFoley, H. M., & Steel, A. E. (2019) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2018.11.003 · Cited by 144
Melatonin effects on sleep, mood, and cognition in elderly with mild cognitive impairment
Jean‐Louis, G., von Gizycki, H., & Zizi, F. (1998) · Journal of Pineal Research · doi:10.1111/j.1600-079x.1998.tb00557.x · Cited by 143 · cited 1×
“In a small pilot study of elderly patients with a mild cognitive deficit, the ability to remember previously learned items improved, and depression decreased with melatonin [106].”
BackgroundSletten, T. L., Magee, M., Murray, J. M., Gordon, C. J., Lovato, N., Kennaway, D. J., Gwini, S. M., Bartlett, D. J., Lockley, S. W., Lack, L. C., et al. (2018) · PLoS Medicine · doi:10.1371/journal.pmed.1002587 · Cited by 142 · cited 2×
“5 mg) an hour before the desired bedtime, along with behavioral strategies for four weeks, resulted in earlier sleep onset, improved sleep efficiency during the first third of the night, and reduced subjective complaints [72].”
BackgroundMelatonin and serotonin profiles in beans of Coffea species
Ramakrishna, A., Giridhar, P., Sankar, K. U., & Ravishankar, G. A. (2011) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00964.x · Cited by 138
Mercolini, L., Mandrioli, R., & Raggi, M. A. (2011) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00967.x · Cited by 135
Artificial light at night: melatonin as a mediator between the environment and epigenome
Haim, A., & Zubidat, A. E. (2015) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2014.0121 · Cited by 133 · cited 1×
“In human models, circadian rhythm disruption due to artificial light exposure at night significantly increased breast cancer risk [193,194].”
BackgroundSafety of higher doses of melatonin in adults: A systematic review and meta-analysis
Menczel Schrire, Z., Phillips, C. L., Chapman, J. L., Duffy, S. L., Wong, G., D’Rozario, A. L., Comas, M., Raisin, I., Saini, B., Gordon, C. J., et al. (2022) · Journal of Pineal Research · doi:10.1111/jpi.12782 · Cited by 133
Physiological melatonin levels in healthy older people: A systematic review
Scholtens, R. M., van Munster, B. C., van Kempen, M. F., & de Rooij, S. E. J. A. (2016) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2016.05.005 · Cited by 132
Inflammaging, Metabolic Syndrome and Melatonin: A Call for Treatment Studies
Cardinali, D. P., & Hardeland, R. (2016) · Neuroendocrinology · doi:10.1159/000446543 · Cited by 131
Cytochrome P 450 isoforms involved in melatonin metabolism in human liver microsomes
Facciolá, G., Hidestrand, M., von Bahr, C., & Tybring, G. (2001) · European Journal of Clinical Pharmacology · doi:10.1007/s002280000245 · Cited by 126
Melatonin the "light of night" in human biology and adolescent idiopathic scoliosis
Grivas, T. B., & Savvidou, O. D. (2007) · Scoliosis · doi:10.1186/1748-7161-2-6 · Cited by 126
Late dinner impairs glucose tolerance in MTNR1B risk allele carriers: A randomized, cross-over study
Lopez-Minguez, J., Saxena, R., Bandín, C., Scheer, F. A., & Garaulet, M. (2018) · Clinical Nutrition · doi:10.1016/j.clnu.2017.04.003 · Cited by 124 · cited 6×
“Those with certain genotypes, such as polymorphisms in the melatonin receptor 1B (MTNR1B) gene, may require mon- itoring of hemoglobin A1C if they take supplemental melatonin [276,277].”
BackgroundInfluentialMelatonin and Female Reproduction: An Expanding Universe
Olcese, J. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00085 · Cited by 123
Neuroendocrine Aspects of Primary Endogenous Depression
Rubín, R. T. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820070052008 · Cited by 121 · cited 1×
“Cortisol and melatonin work inversely, so as cortisol rises, melatonin decreases and vice versa [188].”
BackgroundDetermination of melatonin and its isomer in foods by liquid chromatography tandem mass spectrometry
Kocadağlı, T., Yılmaz, C., & Gökmen, V. (2013) · Food Chemistry · doi:10.1016/j.foodchem.2013.12.036 · Cited by 121
Purslane: a plant source of omega‐3 fatty acids and melatonin
Simopoulos, A. P., Tan, D., Manchester, L. C., & Reiter, R. J. (2005) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2005.00269.x · Cited by 119
Impact of Melatonin on Skeletal Muscle and Exercise
Stacchiotti, A., Favero, G., & Rodella, L. F. (2020) · Cells · doi:10.3390/cells9020288 · Cited by 116 · cited 2×
“Furthermore, these authors suggested that it would be interesting to explore melatonin’s effect on the gut microbiome as it relates to skeletal muscle (the ‘gutmuscle axis’) [199].”
BackgroundVitalini, S., Gardana, C., Simonetti, P., Fico, G., & Iriti, M. (2012) · Journal of Pineal Research · doi:10.1111/jpi.12028 · Cited by 115
Karasek, M., & Winczyk, K. (2006) · PubMed · Cited by 111
Protective Effects of Melatonin on the Skin: Future Perspectives
Rusanova, I., Martínez-Ruiz, L., Florido, J., Rodríguez-Santana, C., Guerra‐Librero, A., Acuña-Castroviejo, D., & Escames, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194948 · Cited by 111 · cited 1×
“In the future, there may be more skincare innovations that involve both vitamin D and melatonin due to the activities they share in the skin [22].”
BackgroundOchoa, J. J., Díaz‐Castro, J., Kajarabille, N., García, C., Guisado-Requena, I. M., de Teresa, C., & Guisado, R. (2011) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00899.x · Cited by 110 · cited 1×
“In a study of oxidative stress markers in those who ran a 50 km (31 m) course, those who took melatonin had reduced levels of stress markers [177], underscoring not only the mechanism of antioxidant protection but also a practical use in athletes who are exposed to oxidative stress and inflammation that may increase t…”
BackgroundEsaki, Y., Kitajima, T., Ito, Y., Koike, S., Nakao, Y., Tsuchiya, A., Hirose, M., & Iwata, N. (2016) · Chronobiology International · doi:10.1080/07420528.2016.1194289 · Cited by 109
Melatonin Promotes Uterine and Placental Health: Potential Molecular Mechanisms
Chuffa, L. G. D. A., Lupi, L. A., Cucielo, M. S., Silveira, H. S., Reiter, R. J., & Seiva, F. R. F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010300 · Cited by 109 · cited 1×
“This nutrient alone is not enough to manage the pain from endometriosis [151,152], but when it comes to pain relief, it may be a safer clinical starting point than pharmaceutical analgesics, which may have significant side effects.”
BackgroundMelatonin biosynthesis pathways in nature and its production in engineered microorganisms
Xie, X.-T., Ding, D., Bai, D., et al. (2022) · Synthetic and Systems Biotechnology · doi:10.1016/j.synbio.2021.12.011 · Cited by 109 · cited 4×
“The enzyme that catalyzes N-acetyl-serotonin into melatonin is N-acetylserotonin methyltransferase (ASMT) [202].”
BackgroundInfluentialPhotic Entrainment of the Circadian System
Ashton, A., Foster, R., & Jagannath, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020729 · Cited by 106 · cited 1×
“Human circadian rhythms are entrained to the environmental day primarily by light exposure, particularly at dawn and dusk [64].”
BackgroundSondrup, N., Termannsen, A., Eriksen, J. N., Hjorth, M. F., Færch, K., Klingenberg, L., & Quist, J. S. (2022) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2022.101594 · Cited by 105
The Potential of Phytomelatonin as a Nutraceutical
B. Arnao, M., & Hernández-Ruiz, J. (2018) · Molecules · doi:10.3390/molecules23010238 · Cited by 102 · cited 1×
“There may also be methodological issues that result in variability in outcomes [211].”
BackgroundMelatonin Target Proteins: Too Many or Not Enough?
Liu, L., Labani, N., Cecon, E., & Jockers, R. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00791 · Cited by 102 · cited 1×
“For example, it has been demonstrated that melatonin can bind several target proteins, including enzymes, receptors, pores, and transporters [17].”
BackgroundMembrane Melatonin Receptors Activated Cell Signaling in Physiology and Disease
Nikolaev, G., Robeva, R. N., & Konakchieva, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010471 · Cited by 101 · cited 2×
“environmental factors like bright light at night [13], medication use [14], and lifestyle [15].”
BackgroundDifferential Effects of Fluvoxamine and Other Antidepressants on the Biotransformation of Melatonin
Härtter, S., Wang, X., Weigmann, H., et al. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200104000-00008 · Cited by 100
Melatonin in mitochondrial dysfunction and related disorders
Srinivasan, V., Spence, D. W., Pandi-Perumal, S. R., Brown, G. M., & Cardinali, D. P. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/326320 · Cited by 100 · cited 1×
“Mitochondrial membranes selectively take up melatonin, a function not shared by other antioxidants [63].”
BackgroundGaraulet, M., Gómez-Abellán, P., Rubio-Sastre, P., Madrid, J. A., Saxena, R., & Scheer, F. A. J. L. (2015) · Metabolism · doi:10.1016/j.metabol.2015.08.003 · Cited by 100 · cited 7×
“Those with certain genotypes, such as polymorphisms in the melatonin receptor 1B (MTNR1B) gene, may require mon- itoring of hemoglobin A1C if they take supplemental melatonin [276,277].”
BackgroundInfluentialSánchez-López, A. L., Ortíz, G. G., Pacheco-Moisés, F. P., Mireles-Ramírez, M. A., Bitzer-Quintero, O. K., Delgado-Lara, D. L. C., Ramírez-Jirano, L. J., & Velázquez-Brizuela, I. E. (2018) · Archives of Medical Research · doi:10.1016/j.arcmed.2018.12.004 · Cited by 100 · cited 1×
“Clinical data investigating melatonin supplementation in individuals with MS have reported better quality of life with lower doses [168] and reduced oxidative stress and inflammatory markers [169,170] in this patient population.”
BackgroundMuñoz-Jurado, A., Escribano, B. M., Caballero‐Villarraso, J., Galván, A., Agüera, E., Santamarı́a, A., & Túnez, I. (2022) · Inflammopharmacology · doi:10.1007/s10787-022-01011-0 · Cited by 100 · cited 1×
“Promising, emerging research indicates that melatonin supplementation may have therapeutic benefits for autoimmune conditions, such as multiple sclerosis (MS) and perhaps Hashimoto’s thyroiditis, most likely due to its involvement in anti-inflammatory mechanisms, oxidative stress reduction, and modulation of the gut m…”
BackgroundLewy, A. J., Emens, J. S., Sack, R. L., Hasler, B. P., & Bernert, R. A. (2002) · Chronobiology International · doi:10.1081/cbi-120004546 · Cited by 99
Day-time melatonin administration: Effects on core temperature and sleep onset latency
REID, K., VAN DEN HEUVEL, C., & DAWSON, D. (1996) · Journal of Sleep Research · doi:10.1046/j.1365-2869.1996.t01-1-00006.x · Cited by 99
Scott, M. B., Styring, A., & McCullagh, J. (2022) · Pathogens · doi:10.3390/pathogens11070770 · Cited by 98 · cited 1×
“Although not absorbed in the GI tract to a great extent, polyphenols have become highlighted for their impacts on gut health, particularly due to the secondary metabolites that form from their interaction with the microbiota [47].”
BackgroundAntioxidant capacity of the neurohormone melatonin
Sofic, E., Rimpapa, Z., Kundurović, Z., Šapčanin, A., Tahirović, I., Rustembegovic, A., & Cao, G. (2005) · Journal of Neural Transmission · doi:10.1007/s00702-004-0270-4 · Cited by 97
Rzepka-Migut, B., & Paprocka, J. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17061916 · Cited by 97
Trends in Use of Melatonin Supplements Among US Adults, 1999-2018
Li, J., Somers, V. K., Xu, H., Lopez-Jimenez, F., & Covassin, N. (2022) · JAMA · doi:10.1001/jama.2021.23652 · Cited by 97
Rizzo, P., Raffone, E., & Benedetto, V. (2010) · PubMed · Cited by 96
The Role of Melatonin in the Treatment of Primary Headache Disorders
Gelfand, A. A., & Goadsby, P. J. (2016) · Headache The Journal of Head and Face Pain · doi:10.1111/head.12862 · Cited by 95
The Crosstalk between Melatonin and Sex Steroid Hormones
Cipolla‐Neto, J., do Amaral, F. G., Soares, J. M., Gallo, C. C., Furtado, A., Cavaco, J. E. B., Gonçalves, I., Santos, C. R. A., & Quintela, T. (2021) · Neuroendocrinology · doi:10.1159/000516148 · Cited by 95 · cited 1×
“Although the data need further delineation, there is a bidirectional relationship between melatonin and sex steroids, especially estrogen, that is determined by many factors [131].”
BackgroundLoss of response to melatonin treatment is associated with slow melatonin metabolism
Braam, W., Van Geijlswijk, I., Keijzer, H., Smits, M. G., Didden, R., & Curfs, L. M. G. (2010) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.2010.01283.x · Cited by 94
Melatonin and Human Cardiovascular Disease
Pandi-Perumal, S. R., BaHammam, A. S., Ojike, N. I., Akinseye, O. A., Kendzerska, T., Buttoo, K., Dhandapany, P. S., Brown, G. M., & Cardinali, D. P. (2016) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248416660622 · Cited by 94
Jet lag: Therapeutic use of melatonin and possible application of melatonin analogs
Srinivasan, V., Spence, D. W., Pandi-Perumal, S. R., Trakht, I., & Cardinali, D. P. (2008) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2007.12.002 · Cited by 93 · cited 1×
“Many studies support melatonin’s use in reducing the ill effects of jet lag and speeding up the normalization of circadian rhythms [73].”
BackgroundZarezadeh, M., Khorshidi, M., Emami, M., Janmohammadi, P., Kord‐Varkaneh, H., Mousavi, S. M., Mohammed, S. H., Saedisomeolia, A., & Alizadeh, S. (2019) · European Journal of Nutrition · doi:10.1007/s00394-019-02123-0 · Cited by 93 · cited 1×
“In a systematic review and meta-analysis of thirteen clinical trials, melatonin supplementation was found to decrease inflammatory compounds (TNF-alpha, IL-6, C-reactive protein), although with a more significant lowering effect on TNF-alpha and IL-6, especially with studies ≥ twelve weeks and at a dosage ≥ 10 mg/day…”
BackgroundMelatonin identified in meats and other food stuffs: potentially nutritional impact
Tan, D. X., Zanghi, B. M., Manchester, L. C., & Reiter, R. J. (2014) · Journal of Pineal Research · doi:10.1111/jpi.12152 · Cited by 92 · cited 1×
“Melatonin has been documented in major plant-derived foods and beverages [212], including vegetables, fruits, nuts, seeds, grains, wine, and beers (see Table 3).”
BackgroundVural, E. M. S., van Munster, B. C., & de Rooij, S. E. (2014) · Drugs & Aging · doi:10.1007/s40266-014-0178-0 · Cited by 92
Labban, S., Alghamdi, B. S., Alshehri, F. S., & Kurdi, M. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.113100 · Cited by 92
Tryptophan: A Unique Role in the Critically Ill
Káňová, M., & Kohout, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111714 · Cited by 92 · cited 1×
“It can stimulate the regeneration of epithelial cells [43] and has also been shown to have protective antioxidant effects on the lining of the GI tract [43].”
BackgroundMelatonin Accumulation in Sweet Cherry and Its Influence on Fruit Quality and Antioxidant Properties
Xia, H., Shen, Y., Shen, T., et al. (2020) · Molecules · doi:10.3390/molecules25030753 · Cited by 91
Melatonin content of pepper and tomato fruits: Effects of cultivar and solar radiation
Riga, P., Medina, S., García-Flores, L. A., & Gil‐Izquierdo, Á. (2014) · Food Chemistry · doi:10.1016/j.foodchem.2014.01.117 · Cited by 89
Elevated heart rate and nondipping heart rate as potential targets for melatonin: a review
Šimko, F., Baka, T., Paulis, L., & Reiter, R. J. (2016) · Journal of Pineal Research · doi:10.1111/jpi.12348 · Cited by 88
Melatonin Treatment May Be Able to Restore Menstrual Cyclicity in Women With PCOS: A Pilot Study
Tagliaferri, V., Romualdi, D., Scarinci, E., De Cicco, S., Di Florio, C., Immediata, V., Tropea, A., Santarsiero, C. M., Lanzone, A., & Apa, R. (2018) · Reproductive Sciences · doi:10.1177/1933719117711262 · Cited by 87 · cited 1×
“Menstrual irregularities decreased in 95% of the women [158].”
BackgroundSimon, S. L., McWhirter, L., Diniz Behn, C., Bubar, K. M., Kaar, J. L., Pyle, L., Rahat, H., Garcia-Reyes, Y., Carreau, A.-M., Wright, K. P., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02385 · Cited by 87 · cited 12×
“This finding suggests that morning circadian misalignment may be part of the pathophysiology of PCOS [154].”
BackgroundInfluentialClinical relevance of melatonin in ovarian and placental physiology: a review
Reiter, R. J., Tan, D., Tamura, H., Cruz, M. H. C., & Fuentes‐Broto, L. (2013) · Gynecological Endocrinology · doi:10.3109/09513590.2013.849238 · Cited by 86 · cited 1×
“Melatonin is relevant for PCOS given that not only are there melatonin receptors on the cells as in other tissues, but melatonin is synthesized in the oocytes, ovarian follicular cells, and cytotrophoblasts of the placenta [154].”
BackgroundAnderson, G., Rodriguez, M., & Reiter, R. J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215500 · Cited by 86 · cited 2×
“Anderson, Rodriguez, and Reiter [170] conducted a systematic review of the correlation between the gut microbiome, gut permeability, and the possible pathophysiology of MS.”
BackgroundPotential utility of melatonin as an antioxidant during pregnancy and in the perinatal period
Aversa, S., Pellegrino, S., Barberi, I., Reiter, R. J., & Gitto, E. (2011) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2011.573827 · Cited by 85 · cited 1×
“According to some research, the use of melatonin supplementation during pregnancy, which has been found safe in both mother and fetus according to some research, could prove to help limit complications during critical periods before and shortly after delivery [133,134].”
Melatonin for the treatment of irritable bowel syndrome
Siah, K. T. H. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i10.2492 · Cited by 85 · cited 3×
“0 mg for IBS-D may benefit patients with IBS [165].”
BackgroundInfluentialPilot Study of the Tart Cherry Juice for the Treatment of Insomnia and Investigation of Mechanisms
Losso, J. N., Finley, J. W., Karki, N., Liu, A. G., Prudente, A. D., Tipton, R., Yu, Y., & Greenway, F. L. (2017) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000000584 · Cited by 82
Mitochondrial dysfunction in age-related macular degeneration: melatonin as a potential treatment
Mehrzadi, S., Hemati, K., Reiter, R. J., & Hosseinzadeh, A. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1737015 · Cited by 82 · cited 1×
“Age-related macular degeneration is another serious ophthalmic condition that theoretically could benefit from melatonin administration, although significant clinical research is currently lacking [101,102].”
BackgroundWilson, L. M., Tharmarajah, S., Jia, Y., Semba, R. D., Schaumberg, D. A., & Robinson, K. A. (2021) · Advances in Nutrition · doi:10.1093/advances/nmab071 · Cited by 82
Nutritional Management of Thyroiditis of Hashimoto
Danailova, Y., Velikova, T. V., Nikolaev, G., Mitova, Z., Shinkov, A. D., Gagov, H., & Konakchieva, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23095144 · Cited by 82 · cited 1×
“While not extensively studied in clinical trials, vitamin D and melatonin have been suggested to be part of a nutritional protocol for individuals with Hashimoto’s thyroiditis due to their molecular actions [172].”
BackgroundKubota, T., Uchiyama, M., Suzuki, H., Shibui, K., Kim, K., Tan, X., Tagaya, H., Okawa, M., & Inoué, S. (2002) · Neuroscience Research · doi:10.1016/s0168-0102(01)00310-8 · Cited by 80 · cited 2×
“environmental factors like bright light at night [13], medication use [14], and lifestyle [15].”
BackgroundZhang, B., Chen, T., Cao, M., Yuan, C., Reiter, R. J., Zhao, Z., Zhao, Y., Chen, L., Fan, W., Wang, X., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.900132 · Cited by 80 · cited 3×
“Levels of gut melatonin can be anywhere from 10 to 100 times greater than melatonin in blood serum levels [37,38].”
BackgroundPharmacokinetics of Alternative Administration Routes of Melatonin: A Systematic Review
Zetner, D. B., Andersen, L., & Rosenberg, J. (2015) · Drug Research · doi:10.1055/s-0035-1565083 · Cited by 79
Treatment of shift work disorder and jet lag
Zee, P. C., & Goldstein, C. A. (2010) · Current Treatment Options in Neurology · doi:10.1007/s11940-010-0090-9 · Cited by 79
Sookprasert, A., Johns, N. P., Phunmanee, A., Pongthai, P., Cheawchanwattana, A., Johns, J. R., Konsil, J., Phiboonchaiyanan, P. P., Porasuphatana, S., & Jitpimolmard, S. (2014) · PubMed · Cited by 79
Celestin, M. N., & Musteata, F. M. (2021) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2021.05.018 · Cited by 79 · cited 1×
“, exposure to artificial blue light at night, jet lag, shift work) or alterations in physiology, such as gene variants in melatonin receptors or metabolic response [2,3].”
BackgroundHuman puberty: Salivary melatonin profiles in constant conditions
Crowley, S. J., Acebo, C., & Carskadon, M. A. (2011) · Developmental Psychobiology · doi:10.1002/dev.20605 · Cited by 78 · cited 2×
“stages of puberty and then slowly decline with age starting in the late twenties [9,10].”
BackgroundPost‐epidemic eosinophilia–myalgia syndrome associated with L‐tryptophan
Allen, J. A., Peterson, A., Sufit, R. L., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30514 · Cited by 78
Micronutrient Inadequacy in Short Sleep: Analysis of the NHANES 2005–2016
Ikonte, C. J., Mun, J. G.-H., Reider, C. A., Grant, R. W., & Mitmesser, S. H. (2019) · Nutrients · doi:10.3390/nu11102335 · Cited by 78 · cited 1×
“From a nutritional standpoint, assessing dietary intake of macronutrients, especially tryptophan-containing sources of protein [87], along with micronutrients such as magnesium [88], vitamin D, and calcium, would be essential for ensuring a biochemical foundation that would foster healthy sleep [89].”
BackgroundNeuroendocrine Aspects of Pregnancy and Postpartum Depression
Trifu, S. C. (2019) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2019.410 · Cited by 78 · cited 1×
“Delivery by cesarean may also be associated with higher levels of pro-inflammatory cytokines compared to vaginal birth [145], thereby shunting the production of pineal gland melatonin synthesis and upregulating the tryptophan conversion into the kynurenic pathway, offsetting the serotonin-melatonin pathway [146].”
BackgroundGaraulet, M., Lopez-Minguez, J., Dashti, H. S., Vetter, C., Hernández-Martínez, A. M., Pérez-Ayala, M., Baraza, J. C., Wang, W., Florez, J. C., Scheer, F. A. J. L., et al. (2022) · Diabetes Care · doi:10.2337/dc21-1314 · Cited by 77 · cited 1×
“In one clinical trial with Spanish type 2 diabetics [130], the relationship between endogenous melatonin, dietary carbohydrate, and the effects of latenight eating were investigated.”
BackgroundCreatine for women in pregnancy for neuroprotection of the fetus
Dickinson, H., Bain, E., Wilkinson, D. J. C., Middleton, P., Crowther, C. A., & Walker, D. W. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010846.pub2 · Cited by 77
Oladi, E., Mohamadi, M., Shamspur, T., & Mostafavi, A. (2014) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2014.05.010 · Cited by 77
Melatonin and metabolic regulation: a review
Navarro‐Alarcón, M., Ruiz‐Ojeda, F. J., Blanca-Herrera, R. M., A‐Serrano, M. M., Acuña-Castroviejo, D., Fernández‐Vázquez, G., & Agil, A. (2014) · Food & Function · doi:10.1039/c4fo00317a · Cited by 77
Breast Milk and the Importance of Chrononutrition
Caba‐Flores, M. D., Ramos-Ligonio, Á., Camacho‐Morales, A., Valenzuela, C., Viveros-Contreras, R., & Caba, M. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.867507 · Cited by 77 · cited 1×
“Breastfed babies have the benefit of melatonin from their mother’s milk [8].”
BackgroundAguilera, Y., Herrera, T., Benítez, V., Arribas, S. M., de Pablo, Á. L. L., Esteban, R. M., & Martin-Cabrejas, M. A. (2014) · Food Chemistry · doi:10.1016/j.foodchem.2014.08.071 · Cited by 75
Parsanathan, R., & Jain, S. K. (2019) · Scientific Reports · doi:10.1038/s41598-019-51377-5 · Cited by 75
Marón, F. J. M., Ferder, L., Reiter, R. J., & Manucha, W. A. (2020) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2020.105595 · Cited by 74 · cited 2×
“It has been proposed that both vitamin D and melatonin orchestrate many of their functions, especially related to redox status, at the level of the mitochondria [27].”
BackgroundPediatric Melatonin Ingestions — United States, 2012–2021
Lelak, K. A., Vohra, V., Neuman, M. I., Toce, M. S., & Sethuraman, U. (2022) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7122a1 · Cited by 73
Jorgensen, K. M., & Witting, M. D. (1998) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(98)70227-6 · Cited by 72
Influence of Circadian Rhythm in the Eye: Significance of Melatonin in Glaucoma
Martínez‐Águila, A., Martín‐Gil, A., Carpena‐Torres, C., Pastrana, C., & Carracedo, G. (2021) · Biomolecules · doi:10.3390/biom11030340 · Cited by 72 · cited 1×
“Some researchers suggest that glaucoma may be a therapeutic target for melatonin [98,99].”
BackgroundCan melatonin improve adaptation to night shift?
James, M., Tremea, M. O., Jones, J. S., & Krohmer, J. R. (1998) · The American Journal of Emergency Medicine · doi:10.1016/s0735-6757(98)90129-2 · Cited by 71
Brinkmann, V., Ale-Agha, N., Haendeler, J., & Ventura, N. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2019.01561 · Cited by 71
Alcoholic fermentation induces melatonin synthesis in orange juice
Fernández‐Pachón, M., Medina, S., Herrero-Martín, G., Cerrillo, I., Berná, G., Escudero‐López, B., Ferreres, F., Martı́n, F., García-Parrilla, M. C., & Gil‐Izquierdo, Á. (2013) · Journal of Pineal Research · doi:10.1111/jpi.12093 · Cited by 69
Anderson, G. (2019) · BioMolecular Concepts · doi:10.1515/bmc-2019-0017 · Cited by 67 · cited 1×
“This nutrient alone is not enough to manage the pain from endometriosis [151,152], but when it comes to pain relief, it may be a safer clinical starting point than pharmaceutical analgesics, which may have significant side effects.”
BackgroundMelatonin in the colon modulates intestinal microbiota in response to stress and sleep deprivation
Park, Y. S., Kim, S. H., Park, J. W., Kho, Y., Seok, P. R., Shin, J.-H., Choi, Y. J., Jun, J.-H., Jung, H. C., & Kim, E. K. (2020) · Intestinal Research · doi:10.5217/ir.2019.00093 · Cited by 67 · cited 2×
“Along these lines of research, melatonin administration in animals helped reduce dysbiosis due to sleep restriction [45,46].”
BackgroundCorrao, S., Bocchio, R. M., Monaco, M. L., Natoli, G., Cavezzi, A., Troiani, E., & Argano, C. (2021) · Nutrients · doi:10.3390/nu13041261 · Cited by 67 · cited 1×
“Although scientific evidence is not definitive, there are some initial indications that melatonin could be beneficial and is also considered to be safe [174,175].”
BackgroundWilliamson, B. L., Tomlinson, A. J., Mishra, P. K., Gleich, G. J., & Naylor, S. (1998) · Chemical Research in Toxicology · doi:10.1021/tx970202h · Cited by 65
Efficacy of Melatonin in prevention of radiation-induced oral mucositis: A randomized clinical trial
Elsabagh, H. H., Moussa, E., Mahmoud, S. A., Elsaka, R. O., & Abdelrahman, H. (2020) · Oral Diseases · doi:10.1111/odi.13265 · Cited by 65
Randomized clinical trial of melatonin after night-shift work: Efficacy and neuropsychologic effects
Wright, S. W., Lawrence, L. M., Wrenn, K. D., Haynes, M. L., Welch, L. W., & Schlack, H. M. (1998) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(98)70010-1 · Cited by 64
Esteban, S., Garau, C., Aparicio, S., Moranta, D., Barceló, P., Fiol-deRoque, M. A., & Rial, R. V. (2010) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2009.00741.x · Cited by 64 · cited 1×
“Thus, researchers are exploring influences on monoamine synthesis, a common target for diseases of the aging brain [108,109], as well as the potential of melatonin as a therapeutic in dementia.”
BackgroundSamara, M. T., Huhn, M., Chiocchia, V., Schneider‐Thoma, J., Wiegand, M. H., Salanti, G., & Leucht, S. (2020) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13201 · Cited by 64
Boafo, A., Greenham, S. L., Alenezi, S., Robillard, R., PAJER, K. A., Tavakoli, P., & Koninck, J. D. (2019) · Nature and Science of Sleep · doi:10.2147/nss.s181365 · Cited by 63
Use of Melatonin in Oxidative Stress Related Neonatal Diseases
D’Angelo, G., Chimenz, R., Reiter, R. J., et al. (2020) · Antioxidants · doi:10.3390/antiox9060477 · Cited by 63
Aguilera, Y., Herrera, T., Liébana, R., Rebollo‐Hernanz, M., Sanchez-Puelles, C., & Martin-Cabrejas, M. A. (2015) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5b03128 · Cited by 62
The Role of Mitochondria in Brain Aging and the Effects of Melatonin
Escames, G., López, A., Garcia, J. A. D., Garcia, L., Acuña-Castroviejo, D., Garcia, J. J., & López, L. C. (2010) · Current Neuropharmacology · doi:10.2174/157015910792246245 · Cited by 62 · cited 1×
“Melatonin is both water- and lipid-soluble (‘amphiphilic’); thereby, it can freely flow among all bodily tissues, especially across the selective blood–brain barrier, making it likely one of the most formidable antioxidants within the central nervous system [60].”
BackgroundMelatonin: shedding light on infertility? - a review of the recent literature
Fernando, S., & Rombauts, L. J. F. (2014) · Journal of Ovarian Research · doi:10.1186/s13048-014-0098-y · Cited by 62
Circadian Rhythms and Melatonin Metabolism in Patients With Disorders of Gut-Brain Interactions
Fowler, S., Hoedt, E. C., Talley, N. J., Keely, S., & Burns, G. L. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.825246 · Cited by 62 · cited 1×
“The release of melatonin in the gut acts in a paracrine manner to increase activity and circulation in the gastric mucosa and enhances GI motility [5,41].”
BackgroundAdamczyk-Sowa, M. H., Pierzchała, K., Sowa, P., Polaniak, R., Kukla, M., & Hartel, M. (2014) · PubMed · Cited by 61
Melatonin in Heart Failure: A Promising Therapeutic Strategy?
Nduhirabandi, F., & Maarman, G. J. (2018) · Molecules · doi:10.3390/molecules23071819 · Cited by 61 · cited 1×
“Other studies have shown that melatonin improves outcomes in patients with heart failure and is considered a preventive and adjunctive curative measure in these patients [124].”
BackgroundEvening wear of blue-blocking glasses for sleep and mood disorders: A systematic review
Hester, L., Dang, D., Barker, C. J., Heath, M., Mesiya, S., Tienabeso, T., & Watson, K. (2021) · Chronobiology International · doi:10.1080/07420528.2021.1930029 · Cited by 60
Melatonin and Related Compounds: Antioxidant and Anti-Inflammatory Actions
Bantounou, M., Plascevic, J., & Galley, H. F. (2022) · Antioxidants · doi:10.3390/antiox11030532 · Cited by 59 · cited 1×
“Both serotonergic and melatonergic systems are also prone to immune and inflammatory responses, adding to the complexities of the gut-brain axis [44].”
BackgroundThe potential therapeutic effect of melatonin in gastro-esophageal reflux disease
Kandil, T. S., Mousa, A. A., El-Gendy, A. A., & Abbas, A. M. (2010) · BMC Gastroenterology · doi:10.1186/1471-230x-10-7 · Cited by 58 · cited 2×
“Additionally, of note is that in one study on GERD, melatonin given at 3 mg daily over eight weeks showed similar improvement in symptoms as omeprazole [164].”
Background
Cited by
Sorted by citations
Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging
Jomova, K., Raptova, R., Alomar, S. Y., Alwasel, S. H., Nepovimova, E., Kuca, K., & Valko, M. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03562-9 · Cited by 2,638
Oxidative Stress, Reductive Stress and Antioxidants in Vascular Pathogenesis and Aging
Mladenov, M. I., Lubomirov, L. T., Grisk, O., Avtanski, D. B., Mitrokhin, V. M., Sazdova, I., Keremidarska‐Markova, M., Danailova, Y., Nikolaev, G., Konakchieva, R., et al. (2023) · Antioxidants · doi:10.3390/antiox12051126 · Cited by 79
“In addition, studies have reported the synergistic actions of melatonin with vitamins C and E [215].”
BackgroundLi, W., Li, W., Zhang, W., et al. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03371-y · Cited by 54
Melatonin Treatment in Kidney Diseases
Markowska, M., Niemczyk, S., & Romejko, K. (2023) · Cells · doi:10.3390/cells12060838 · Cited by 44
“Not only is the role of melatonin in human gendering important, its support is also necessary when neonatal pathologies occur [62,63].”
BackgroundThe potential influence of melatonin on mitochondrial quality control: a review
Lei, X., Xu, Z., Huang, L., Huang, Y., Tu, S., Xu, L., & Liu, D. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1332567 · Cited by 36
“In mammals, melatonin is produced in many organs such as the pineal, small intestine, retina, brain, liver, thymus, kidney, skin, and other tissues (Minich et al., 2022).”
BackgroundInfluential
Metadata
- Authors
- Minich, D. M., Henning, M., Darley, C., Fahoum, M., Schuler, C. B., & Frame, J.
- Affiliations
- University of Western States (US)
- University of the Rockies (US)
- National University of Natural Medicine (US)
- Bastyr University (US)
- School of Nutrition, Sonoran University of Health Sciences, Tempe, AZ 85282, USA
- Natural Health International Pty., Ltd., Sydney, NSW 2000, Australia
- Corresponding author
- Minich, Deanna M.
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2022-09-22
- Volume
- 14
- Issue
- 19
- Pages
- 3934
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC9571539
- OpenAlex
- W4296829676
- Semantic Scholar
- e2efdb871a3ef1f27a752431bf3a072a4deb68ea
- Cited by
- 176
- References
- 339
- Citations by year
- 2026: 39 · 2025: 63 · 2024: 37 · 2023: 34 · 2022: 3
- FWCI
- 4.94
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Symphony Natural Health
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Vitamin D Research Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › melanin and skin pigmentation
- Keywords
- melatonin, dietary supplements, sleep, antioxidant activity, immunomodulation, anti-inflammatory activity, mitochondrial regulation, vitamin D, blue light exposure, melatonin deficiency, supplement safety, phytomelatonin, Alzheimer's disease, cancer, multiple sclerosis, polycystic ovary syndrome, fertility, COVID-19 pandemic
- MeSH terms
- COVID-19, Animals, Antioxidants, Circadian Rhythm, Humans, Melatonin, Vitamin D, Vitamins, Dietary Supplements, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review